<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD003518.pub2" GROUP_ID="PREG" ID="692000061313270300" MERGED_FROM="" MODIFIED="2012-02-10 14:29:25 +0100" MODIFIED_BY="Sonja Henderson" REVIEW_NO="0331" REVMAN_SUB_VERSION="5.1.6" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="8.0">
<COVER_SHEET MODIFIED="2012-02-10 14:29:25 +0100" MODIFIED_BY="Sonja Henderson">
<TITLE MODIFIED="2011-01-25 12:47:00 +0000" MODIFIED_BY="Lynn Hampson">Expectant care versus surgical treatment for miscarriage</TITLE>
<CONTACT MODIFIED="2012-02-10 14:29:25 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="9162" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Kavita</FIRST_NAME><LAST_NAME>Nanda</LAST_NAME><POSITION>Scientist</POSITION><EMAIL_1>knanda@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI</ORGANISATION><ADDRESS_1>P.O. Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 507</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-02-10 14:29:25 +0100" MODIFIED_BY="Sonja Henderson"><PERSON ID="9162" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Kavita</FIRST_NAME><LAST_NAME>Nanda</LAST_NAME><POSITION>Scientist</POSITION><EMAIL_1>knanda@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI</ORGANISATION><ADDRESS_1>P.O. Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 507</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON><PERSON ID="3B53A95682E26AA20114382D371E0DCB" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Laureen</FIRST_NAME><MIDDLE_INITIALS>M</MIDDLE_INITIALS><LAST_NAME>Lopez</LAST_NAME><EMAIL_1>llopez@fhi360.org</EMAIL_1><ADDRESS><DEPARTMENT>Clinical Sciences</DEPARTMENT><ORGANISATION>FHI 360</ORGANISATION><ADDRESS_1>P.O. Box 13950</ADDRESS_1><CITY>Research Triangle Park</CITY><ZIP>27709</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>+1 919 5447040 ext: 11443</PHONE_1><FAX_1>+1 919 5447261</FAX_1></ADDRESS></PERSON><PERSON ID="4664" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>David</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Grimes</LAST_NAME><POSITION>Clinical Professor</POSITION><EMAIL_1>david_grimes@med.unc.edu</EMAIL_1><MOBILE_PHONE>919-656-7227</MOBILE_PHONE><ADDRESS><DEPARTMENT>Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>University of North Carolina School of Medicine</ORGANISATION><ADDRESS_1>CB #7570</ADDRESS_1><CITY>Chapel Hill</CITY><ZIP>27599-7570</ZIP><REGION>North Carolina</REGION><COUNTRY CODE="US">USA</COUNTRY><PHONE_1>919-656-7227</PHONE_1></ADDRESS></PERSON><PERSON ID="15987" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Alessandra</FIRST_NAME><LAST_NAME>Peloggia</LAST_NAME><EMAIL_1>apeloggia@hotmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynecology</DEPARTMENT><ORGANISATION>State University of Campinas (UNICAMP)</ORGANISATION><ADDRESS_1>Caixa Postal 6181</ADDRESS_1><CITY>Campinas</CITY><ZIP>13084-971</ZIP><REGION>São Paulo</REGION><COUNTRY CODE="BR">Brazil</COUNTRY><PHONE_1>+55 19 32892856</PHONE_1><PHONE_2>+55 12 91827539</PHONE_2><FAX_1>+55 19  32892440</FAX_1></ADDRESS></PERSON><PERSON ID="15974" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Geeta</FIRST_NAME><LAST_NAME>Nanda</LAST_NAME><EMAIL_1>geeta_nanda@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>C/o Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health</DEPARTMENT><ORGANISATION>The University of Liverpool</ORGANISATION><ADDRESS_1>First Floor, Liverpool Women's NHS Foundation Trust</ADDRESS_1><ADDRESS_2>Crown Street</ADDRESS_2><CITY>Liverpool</CITY><ZIP>L8 7SS</ZIP><COUNTRY CODE="GB">UK</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-02-10 13:13:21 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="10" MONTH="2" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="11" MONTH="1" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="17" MONTH="5" YEAR="2013"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="2002"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2006"/>
<LAST_CITATION_ISSUE ISSUE="2" YEAR="2006"/>
</DATES>
<WHATS_NEW MODIFIED="2012-02-10 13:13:42 +0000" MODIFIED_BY="Denise Atherton">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2012-02-10 13:13:42 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Review now includes significant results for the outcomes of 'need for blood transfusion' (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>) and 'cost' (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). The outcome 'infection' is no longer significant (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-02-10 13:13:12 +0000" MODIFIED_BY="Denise Atherton">
<DATE DAY="11" MONTH="1" YEAR="2012"/>
<DESCRIPTION>
<P>Search updated. One new trial report identified (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>). This has been included. For the trial reports identified from the previous search, we have included one trial (<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>), excluded one trial (<LINK REF="STD-Smith-2006" TYPE="STUDY">Smith 2006</LINK>) and identified an additional report of the <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> (included study). One study, previously ongoing, has now been excluded (<LINK REF="STD-Schwarzler-2003" TYPE="STUDY">Schwarzler 2003</LINK>).</P>
<P>This review is now comprised of seven trials with 1521 women.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2011-06-20 12:22:49 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2011-01-25 17:54:39 +0000" MODIFIED_BY="Laureen M Lopez">
<DATE DAY="1" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Five reports added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (Petrou 2006; Smith 2006; Smith 2006a; Trinder 2006a; Wieringa-De 2004a).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-26 12:14:57 +0000" MODIFIED_BY="Jill V Hampson">
<DATE DAY="2" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES/>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>United States Agency for International Development</NAME>
<COUNTRY CODE="US">USA</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-02-10 13:21:20 +0000" MODIFIED_BY="Denise Atherton">
<SUMMARY MODIFIED="2012-02-07 15:23:44 +0000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2008-10-21 11:11:13 +0100" MODIFIED_BY="Sonja Henderson">Expectant care (waiting) versus surgical treatment for miscarriage</TITLE>
<SUMMARY_BODY MODIFIED="2012-02-07 15:23:44 +0000" MODIFIED_BY="[Empty name]">
<P>Miscarriage is pregnancy failure before 14 weeks, which is common in early pregnancy. Such a loss in early pregnancy can affect a woman&#8217;s physical and mental health. Doctors often suggest surgery such as dilation and curettage (D and C) or vacuum aspiration to complete the process. Surgery might cause problems such as trauma, heavy bleeding, or infection. Expectant management means waiting for the miscarriage to finish on its own, and may involve bed rest, examination by ultrasound, and antibiotics. This review looked at whether expectant management works as well as surgery for miscarriage.</P>
<P>We searched for randomized trials that compared waiting versus surgery for miscarriage. In addition, we looked at reference lists to find trials. We also wrote to researchers to find more studies. Seven trials with 1521 women looked at waiting versus surgery for miscarriage. More women who waited for the miscarriage to complete on its own had tissue left in the womb. This was studied at two weeks and at six to eight weeks. More of these women needed surgery to complete the process. These women also had more days of bleeding. Some needed to be given blood, compared with none in the surgery group. Both groups had about the same numbers of infections. Results were mixed for pain. Mental health also seemed about the same for both treatment groups. Costs were lower for waiting than for surgery. Overall, no strong medical results argue for either approach. Information was limited on future pregnancy. One trial was large, while the others had small numbers of women. What the woman prefers should be the major concern. Drug treatment (such as with misoprostol and mifepristone) has added choices for women and their clinicians, and has been studied in other reviews.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-02-10 13:14:50 +0000" MODIFIED_BY="Denise Atherton">
<ABS_BACKGROUND MODIFIED="2012-02-07 15:23:06 +0000" MODIFIED_BY="Heather Maxwell">
<P>Miscarriage is a common complication of early pregnancy that can have both medical and psychological consequences such as depression and anxiety. The need for routine surgical evacuation with miscarriage has been questioned because of potential complications such as cervical trauma, uterine perforation, hemorrhage, or infection.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2011-12-01 16:27:54 +0000" MODIFIED_BY="Laureen M Lopez">
<P>To compare the safety and effectiveness of expectant management versus surgical treatment for early pregnancy failure.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-02-10 13:14:50 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (9 February 2012), the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library </I>2011, Issue 4 of 4), PubMed (2005 to 11 January 2012), POPLINE (inception to 11 January 2012), LILACS (2005 to 11 January 2012) and reference lists of retrieved studies.</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2011-05-23 19:36:17 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized trials comparing expectant care and surgical treatment (vacuum aspiration or dilation and curettage) for miscarriage were eligible for inclusion.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-02-09 13:46:52 +0000" MODIFIED_BY="Denise Atherton">
<P>Two review authors assessed trial quality and extracted data. We contacted study authors for additional information. For dichotomous data, we calculated the Mantel-Haenszel risk ratio (RR) with 95% confidence interval (CI). For continuous data, we computed the mean difference (MD) and 95% CI. We entered additional data such as medians into 'Other data' tables.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-02-07 15:23:29 +0000" MODIFIED_BY="Denise Atherton">
<P>We included seven trials with 1521 participants in this review. The expectant-care group was more likely to have an incomplete miscarriage by two weeks (RR 3.98; 95% CI 2.94 to 5.38) or by six to eight weeks (RR 2.56; 95% CI 1.15 to 5.69). The need for unplanned surgical treatment was greater for the expectant-care group (RR 7.35; 95% CI 5.04 to 10.72). The mean percentage needing surgical management in the expectant-care group was 28%, while 4% of the surgical-treatment group needed additional surgery. The expectant-care group had more days of bleeding (MD 1.59; 95% CI 0.74 to 2.45). Further, more of the expectant-care group needed transfusion (RR 6.45; 95% CI 1.21 to 34.42). The mean percentage needing blood transfusion was 1.4% for expectant care compared with none for surgical management. Results were mixed for pain. Diagnosis of infection was similar for the two groups (RR 0.63; 95% CI 0.36 to 1.12), as were results for various psychological outcomes. Pregnancy data were limited. Costs were lower for the expectant-care group (MD -499.10; 95% CI -613.04 to -385.16; in UK pounds sterling).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-01-11 15:55:32 +0000" MODIFIED_BY="[Empty name]">
<P>Expectant management led to a higher risk of incomplete miscarriage, need for unplanned (or additional) surgical emptying of the uterus, bleeding and need for transfusion. Risk of infection and psychological outcomes were similar for both groups. Costs were lower for expectant management. Given the lack of clear superiority of either approach, the woman's preference should be important in decision making. Pharmacological ('medical') management has added choices for women and their clinicians and has been examined in other reviews.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-02-10 13:21:20 +0000" MODIFIED_BY="Denise Atherton">
<BACKGROUND MODIFIED="2012-02-07 15:23:50 +0000" MODIFIED_BY="Denise Atherton">
<P>Miscarriage is a common outcome of pregnancy (15% to 20%) (<LINK REF="REF-Hemminki-1998" TYPE="REFERENCE">Hemminki 1998</LINK>), which can have both medical and psychological consequences. Medical complications include infection, hemorrhage, embolism, and complications of anesthesia (<LINK REF="REF-Saraiya-1999" TYPE="REFERENCE">Saraiya 1999</LINK>). Psychological consequences include depression and anxiety, for both the woman and her partner (<LINK REF="REF-Conway-2000" TYPE="REFERENCE">Conway 2000</LINK>; <LINK REF="REF-Geller-2001" TYPE="REFERENCE">Geller 2001</LINK>; <LINK REF="REF-Neugebauer-1997" TYPE="REFERENCE">Neugebauer 1997</LINK>).</P>
<P>The terminology of miscarriage has been confusing to providers and to women. Terms used for describing the underlying pathologic abnormality include anembryonic pregnancy (trophoblast development without development of an embryo); embryonic death (an embryo greater than 5 mm, up to eight-week size, with no cardiac activity on ultrasound examination); and fetal death (death after eight weeks). The terms used to describe the process of miscarriage are incomplete miscarriage (passage of some pregnancy-related tissue, along with clinical or ultrasonic evidence of retained tissue) and inevitable miscarriage (bleeding without passage of tissue but with an open cervix). Common terms for miscarriage, such as 'missed abortion' and 'blighted ovum', do not reflect current understanding of early pregnancy physiology (<LINK REF="REF-Chen-2007" TYPE="REFERENCE">Chen 2007</LINK>). 'Missed abortion' refers to a pregnancy that is retained for a prolonged time after its death. 'Blighted ovum' is another inaccurate and outdated term that implies failure or absence of an embryo at a very early stage of pregnancy. The preferred term today is 'early pregnancy failure' (<LINK REF="REF-Chen-2007" TYPE="REFERENCE">Chen 2007</LINK>; <LINK REF="REF-Dalton-2009" TYPE="REFERENCE">Dalton 2009</LINK>).</P>
<P>Historically, physicians believed that all miscarriages should be considered incomplete, and that the potential complications of retained placental tissue justified surgical evacuation in all cases. When surgical intervention is needed, suction curettage is superior to sharp curettage with a rigid metal curette (<LINK REF="REF-WHO-2003" TYPE="REFERENCE">WHO 2003</LINK>). Sharp curettage is obsolete and should have little use in gynecology. Although suction curettage (vacuum aspiration or manual vacuum aspiration) has replaced sharp curettage in developed countries, it is less common in developing countries due to lack of experience and equipment. In countries where abortion is illegal, or where women have limited access to abortion, the management of miscarriage is complicated by ambiguity regarding whether the miscarriage was truly spontaneous or illegally induced. Surgical treatment has also been the standard management for pregnancies that are found to be non-viable on early ultrasound.</P>
<P>The natural course of early pregnancy failure is unknown, however, and the need for routine surgical evacuation has been questioned (<LINK REF="REF-Ballagh-1998" TYPE="REFERENCE">Ballagh 1998</LINK>). Surgical evacuation may lead to cervical trauma, uterine perforation, or intrauterine adhesions. Postoperative endometritis is another potential complication. Pelvic ultrasound examination has been suggested as a way to determine the presence or absence of retained tissue and need for further intervention. Medical management of miscarriage with agents such as misoprostol or the progesterone antagonist mifepristone has also been proposed as an alternative to surgical treatment (<LINK REF="REF-Chen-2007" TYPE="REFERENCE">Chen 2007</LINK>). The literature on expectant management is sparse and features a wide range of success rates. Moreover, data on the acceptability of different management strategies are limited (<LINK REF="REF-Sotiriadis-2005" TYPE="REFERENCE">Sotiriadis 2005</LINK>).</P>
<P>Some clinicians recommend surgical intervention to avoid the uncertainty regarding passage of tissue with expectant management, since the woman may be upset during the wait (<LINK REF="REF-Sharma-1993" TYPE="REFERENCE">Sharma 1993</LINK>). In a survey of women attending a family planning clinic, respondents were asked about their preferred therapy if they were to experience a miscarriage in the future. Most indicated a strong preference for expectant treatment, but the physician's recommendation would clearly influence their decision (<LINK REF="REF-Molnar-2000" TYPE="REFERENCE">Molnar 2000</LINK>). In Michigan (USA), most women with early pregnancy failure are managed with either suction curettage or expectant management (<LINK REF="REF-Dalton-2009" TYPE="REFERENCE">Dalton 2009</LINK>).</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2011-12-01 16:28:02 +0000" MODIFIED_BY="[Empty name]">
<P>To compare the effectiveness and safety of expectant management versus surgical treatment for early pregnancy failure.</P>
</OBJECTIVES>
<METHODS MODIFIED="2012-02-10 13:19:33 +0000" MODIFIED_BY="Denise Atherton">
<SELECTION_CRITERIA MODIFIED="2012-02-07 09:41:49 +0000" MODIFIED_BY="Denise Atherton">
<CRIT_STUDIES>
<P>All published, unpublished, and ongoing randomized trials with available data that compared outcomes between women treated surgically and women managed expectantly for miscarriage as defined above. Trials must have included random allocation to treatment and comparison groups.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-02-07 09:41:49 +0000" MODIFIED_BY="[Empty name]">
<P>Women with miscarriage (spontaneous pregnancy loss at less than 14 weeks gestation), with either ultrasound evidence of retained tissue, or with a clinical diagnosis of inevitable miscarriage or incomplete miscarriage (where there could be uncertainty as to whether any tissue remains in the uterus). In addition, we included women with ultrasound evidence of non-viable pregnancies at less than 14 weeks gestation.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-01-11 15:34:45 +0000" MODIFIED_BY="Frances J Kellie">
<P>Expectant management excluded any surgical or medical (drug) treatment for miscarriage, but allowed bedrest, ultrasound examination, and antibiotics. Expectant management was compared with any type of surgical treatment, such as manual vacuum aspiration, suction curettage, and sharp curettage (with or without dilation). Surgical treatment could have been with or without bedrest, ultrasound examination, or antibiotics.</P>
<SUBSECTION>
<HEADING LEVEL="4">Exclusion criteria</HEADING>
<OL>
<LI>Studies comparing different methods of induced abortion.</LI>
<LI>Studies comparing different medical treatments for miscarriage.</LI>
<LI>Studies comparing expectant care versus medical treatment for miscarriage.</LI>
<LI>Studies comparing surgery versus medical treatment for miscarriage.</LI>
<LI>Studies comparing different surgical methods for miscarriage.</LI>
</OL>
</SUBSECTION>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2011-08-15 16:34:46 +0100" MODIFIED_BY="Denise Atherton">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2011-08-15 16:34:40 +0100" MODIFIED_BY="Denise Atherton">
<OL>
<LI>Incomplete miscarriage (based on clinical findings of retained tissue at operation or ultrasound examination after a specific time period).</LI>
<LI>Need for unplanned (or additional) surgical evacuation (such as vacuum aspiration).</LI>
<LI>Complications, such as uterine perforation, complication requiring hysterectomy, need for admission to intensive care unit, or severe sepsis (associated organ dysfunction, hypoperfusion abnormality, or sepsis-induced hypotension).</LI>
<LI>Localized pelvic infection.</LI>
<LI>Need for blood transfusion.</LI>
<LI>Death.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2011-08-15 16:34:46 +0100" MODIFIED_BY="Denise Atherton">
<OL>
<LI>Days of bleeding.</LI>
<LI>Discomfort or pain.</LI>
<LI>Psychological outcomes (women's preferences or satisfaction with therapy, as well as depression and anxiety).</LI>
<LI>Costs (all reported direct and indirect costs from all reported perspectives).</LI>
<LI>Intrauterine adhesions.</LI>
<LI>Subsequent fertility (since all women do not attempt pregnancy, the denominator of this outcome was limited).</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-02-10 13:19:33 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-02-10 13:19:33 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Coordinator (9 February 2012).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Coordinator and contains trials identified from: </P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of EMBASE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and EMBASE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.  </P>
<P>In addition, we searched the Cochrane Central Register of Controlled Trials (<I>The Cochrane Library </I>2011, Issue 4 of 4), PubMed (1 January 2005 to 11 January 2012), POPLINE (inception to 11 January 2012) and LILACS (1 January 2005 to 11 January 2012). The search strategies are given in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>Details of additional searching conducted for the initial version of this review are shown in<I> </I>
<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2011-06-06 18:56:43 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the reference lists of retrieved studies. </P>
<P>We did not apply any language restrictions.</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-02-07 15:28:59 +0000" MODIFIED_BY="Denise Atherton">
<P>For this update, we used the methods described below when assessing the trials included from the new searches (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>). <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> has the methods used for the initial review, which was published in 2006.</P>
<STUDY_SELECTION MODIFIED="2012-02-07 15:28:59 +0000" MODIFIED_BY="Denise Atherton">
<P>We evaluated the trials using standard criteria without consideration of results (<LINK REF="REF-Alderson-2004" TYPE="REFERENCE">Alderson 2004</LINK>; <LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>). Two authors reviewed trials identified by the search strategy. We excluded trials without random allocation without further evaluation. We resolved discrepancies or disagreements by discussion or, if needed, through consultation with a third review author.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2011-05-23 20:01:24 +0100" MODIFIED_BY="[Empty name]">
<P>For eligible studies, two review authors extracted the data. We resolved discrepancies through discussion or, if required, consultation with a third author. One author entered data into <LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK> and a second author checked the entries for accuracy. When information in the reports was unclear, we attempted to contact authors of the original reports for further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-02-07 11:09:18 +0000" MODIFIED_BY="Denise Atherton">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved any disagreement by discussion or by involving a third assessor. For details, see <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>, 'Risk of bias' tables.</P>
<SUBSECTION>
<HEADING LEVEL="4">Adequate sequence generation</HEADING>
<P>We have listed the methods described in the reports. The risk of bias for methods in the included studies could be:</P>
<UL>
<LI>low (adequate) - e.g., random number table or computer-generated random numbers; telephone or central randomization;</LI>
<LI>unclear - insufficient information available on how the randomization sequence was generated;</LI>
<LI>high (inadequate) - study may have used a non-random process, e.g., odd or even date of birth; hospital or clinic record number. However, we noted in the protocol that we would only include randomized controlled trials (<LINK TAG="SELECTION_CRITERIA" TYPE="SECTION">Criteria for considering studies for this review</LINK>).</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Allocation concealment</HEADING>
<P>We have noted whether allocation was concealed before assignment. We also provided information on whether the risk of bias for concealment appeared to be:</P>
<UL>
<LI>low (adequate method) - telephone or central randomization; consecutively-numbered sealed opaque envelopes;</LI>
<LI>unclear - insufficient information available to determine the adequacy of the methods, e.g., whether envelopes were opaque or not;</LI>
<LI>high (inadequate method) - e.g., open allocation.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Blinding</HEADING>
<P>Blinding of participants or study clinicians was not feasible for the interventions examined in this review. We searched the reports for methods used to blind assessors from knowledge of which intervention a participant received. The risk of bias could be:</P>
<UL>
<LI>low - assessors blinded to study arm;</LI>
<LI>unclear - insufficient information to determine whether any blinding of assessors occurred;</LI>
<LI>high - assessors were not blinded to study arm.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Incomplete outcome data addressed</HEADING>
<P>We describe the completeness of data, including losses to follow up and exclusions from the analysis, for the relevant outcomes. We noted reasons for losses or exclusions if available, and whether there were differential losses across the study groups. We noted whether incomplete outcome data was addressed. The risk of bias could be:</P>
<UL>
<LI>low (adequate method) - loss information reported, losses less than or equal to 20% and similar across study arms, no inappropriate exclusions after randomization;</LI>
<LI>unclear - report did not provide information on losses or any exclusions;</LI>
<LI>high (inadequate method) - losses greater than 20% or losses differed substantially by study arm, inappropriate exclusions after randomization.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Free of selective reporting</HEADING>
<P>We examined each report for any evidence of selective outcome reporting. We assessed whether studies appeared to be free of selective reporting and the risk of bias was assessed as:</P>
<UL>
<LI>low (adequate method) - all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported;</LI>
<LI>unclear - insufficient information available to determine if selective reporting occurred;</LI>
<LI>high (inadequate method) - the study&#8217;s pre-specified outcomes were not reported; one or more primary outcomes were not pre-specified; results of an expected key outcome were not reported.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Other sources of bias</HEADING>
<P>Where relevant, we list any important concerns we have about other possible sources of bias. These might include study being stopped early or study arms appearing unbalanced compared to the randomization information provided. We assessed whether each study appeared to be free of other sources of bias. The risk of bias was could be:</P>
<UL>
<LI>low - no other apparent source of significant bias;</LI>
<LI>unclear - other bias possible but insufficient information available to determine the extent;</LI>
<LI>high - other source of bias likely, e.g., study funding source or potential conflicts of researchers.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Overall risk of bias</HEADING>
<P>We judged whether studies were at high risk of bias, according to the criteria in <LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>. With the criteria above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to have affected the results.  We explored the impact of the level of bias through <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-02-07 15:25:13 +0000" MODIFIED_BY="Denise Atherton">
<P>For dichotomous data, we calculated the Mantel-Haenszel risk ratio (RR) with 95% confidence interval (CI) using a fixed-effect model. For continuous data, if outcomes were measured in a similar way across trials, we computed the mean difference (MD) and 95% CI, also using a fixed-effect model. RevMan uses the inverse variance approach. We entered additional data such as medians into 'Other data' tables.</P>
</EFFECT_MEASURES>
<MISSING_DATA MODIFIED="2012-02-07 11:09:25 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, we noted losses to follow up or exclusions, but did not find any with high rates. The data in the present review were generally based on the analytic method used in the trial report (for example, intention-
to-
treat or per protocol). Any reasons for exception are given with the results. Where possible, we included all participants randomized to each group in the analyses, as per the group to which they were allocated. The denominator for each outcome in each trial is the number randomized minus any participants whose outcomes were missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2011-12-01 16:17:36 +0000" MODIFIED_BY="Denise Atherton">
<P>We assessed statistical heterogeneity in each meta-analysis using the I² and Chi² statistics. We determined substantial heterogeneity to be present if I² was greater than 50% or if P &lt; 0.10 in the Chi² test for heterogeneity.</P>
<P>We also looked for clinical heterogeneity, that is, variability in types of participants, interventions, or outcomes. However, we did not combine outcomes in a meta-analysis if they were very different.</P>
</HETEROGENEITY_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-02-07 15:25:22 +0000" MODIFIED_BY="Denise Atherton">
<P>
<LINK REF="REF-RevMan-2011" TYPE="REFERENCE">RevMan 2011</LINK> was used for statistical analysis. We used fixed-effect meta-analysis for combining data where the trials examined the same intervention and the trials&#8217; populations and methods were sufficiently similar. In the <LINK TAG="RESULTS" TYPE="SECTION">Results</LINK>, we emphasized the important differences. That is, we included the estimates and CIs for the meta-analyses as well as other results that were significant (P &lt; 0.05). The less important findings are mentioned, and the specific numbers can be found in the tables and figures.</P>
<P>After conducting the review, we assessed the quality of evidence using the GRADE approach (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). Grades could be high (randomized controlled trial), moderate, low, or very low. Randomized controlled trials were downgraded one level for each of the following: outcome was subject to bias due to the assessor not being blinded or self-report; losses were greater than 20% for the specific outcome. We presented the results for the meta-analyses in <LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>. Outcomes for which we could not conduct meta-analysis are summarized in <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-02-07 09:58:53 +0000" MODIFIED_BY="Laureen M Lopez">
<P>In a subgroup analysis, we intended to examine outcomes for incomplete or inevitable miscarriage (where bleeding has already begun) versus non-viable pregnancy (without bleeding). For the participants having ultrasound examination, we also intended to examine outcomes for embryonic death (less than eight weeks gestation) versus fetal death (at least eight weeks gestation). However, we found no studies that reported data separately for non-viable pregnancies documented by ultrasound examination.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-02-07 09:59:43 +0000" MODIFIED_BY="Laureen M Lopez">
<P>We had planned to remove studies with high losses in a sensitivity analysis. However, we did not have any included trials with known high losses. Some did not specify losses but the analyses generally appeared to include all women in their originally assigned groups. Due to the risk of bias in <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>, we examined each meta-analysis containing that trial. We looked at whether the direction or significance of the results changed when <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was removed from the analysis. Similarly, because the exact time frames for the assessments in <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> were unknown, we examined any meta-analysis containing that trial, with and without the <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997 </LINK>data.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-02-10 13:21:20 +0000" MODIFIED_BY="Denise Atherton">
<STUDY_DESCRIPTION MODIFIED="2012-02-10 13:21:20 +0000" MODIFIED_BY="Denise Atherton">
<P>An updated search of the Pregnancy and Childbirth Group's Trials Register identified one new trial report (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>), which has been included. For the trial reports identified from the previous search (October 2009) we have included one trial (<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>), excluded one trial (<LINK REF="STD-Smith-2006" TYPE="STUDY">Smith 2006</LINK>) and identified an additional report of the <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> (included study). One study, previously ongoing, has now been excluded (<LINK REF="STD-Schwarzler-2003" TYPE="STUDY">Schwarzler 2003</LINK>).</P>
<P>This updated review is now comprised of seven included studies and 10 excluded studies (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>). One trial report is awaiting classification in the next update (<LINK REF="STD-Wijesinghe-2011" TYPE="STUDY">Wijesinghe 2011</LINK>).</P>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-02-07 10:02:03 +0000" MODIFIED_BY="Denise Atherton">
<P>Seven trials are now included in this review (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). The studies compared expectant care versus surgical management of early pregnancy loss. Six trials reported on successful treatment, retained products of miscarriage, or the need for additional treatment. Only <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> did not report on these primary outcomes, but did provide data for the primary outcome of pelvic infection.</P>
<P>Observation periods varied across the studies. All but <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> had at least a short-term follow-up of two weeks or less. <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK> assessed the women seven to 10 days after randomization or the procedure. <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> followed the women in both expectant and surgical groups at three and 14 days after randomization. <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> provided data from two weeks after randomization, as well as data on complete miscarriages at seven weeks. <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> reported measures at six weeks after allocation to the study arm. <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> conducted assessments at one and two weeks and at six months. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> assessed the outcomes at two and eight weeks. <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> used a 10- to 14-day visit and an eight-week follow-up.</P>
<P>Some of these studies were limited by their sample sizes, with three having fewer than 100 participants (<LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>). Three addressed sample size or power (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>), and all three had planned larger samples. <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> had estimated 162 were needed, but only 122 of 449 eligible women consented to randomization. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> planned a sample size of 831. Recruitment was stopped after 1.5 years, because less than 50% eligible women had been approached to participate, and only 22% of those agreed to be randomized. <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> had planned a sample size of 1422. Due to slow recruitment, even with an additional 33 months of recruitment, only 1200 were randomized.</P>
<P>For further information, <I>see</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</INCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-02-07 15:25:43 +0000" MODIFIED_BY="Denise Atherton">
<ALLOCATION MODIFIED="2012-02-07 15:25:36 +0000" MODIFIED_BY="Denise Atherton">
<P>Three trials used central electronic randomization systems (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>) and therefore, were rated as 'low risk of bias' for sequence generation and allocation concealment. The randomization process was unclear in four studies. <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> and <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> did not provide information on the randomization methods, and the disparity in treatment group sizes in <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> raises concern. The likelihood of getting a disparity this large (122 versus 161) with simple randomization is 1% by binomial distribution. The trial was rated as 'high risk' for randomization sequence. No information was provided on whether there was some crossover from assigned to actual group. <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK> and <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> allocated participants using sealed envelopes, but did not specify whether the envelopes were opaque or sequentially numbered. Mixing of the envelopes was not specified.</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-02-07 15:25:43 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Given the nature of the intervention, patients and clinicians involved in the procedures could not be blinded to the method of management. Whether those assessing the clinical outcomes were blinded to the group assignment is unknown.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-02-07 11:10:00 +0000" MODIFIED_BY="Denise Atherton">
<P>No study had identifiable high losses. Most of the earlier studies did not report losses. <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK> excluded three of the original 97 women from the analysis due to one withdrawal, one ectopic pregnancy, and one loss to follow up. The primary analysis for three trials appeared to include all randomized women in their originally assigned groups (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). Some studies reported cross-over numbers, as women who had been allocated to the expectant-care group later requested surgical treatment. These included 25 women in <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> and one in <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>. Apart from <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>, studies were rated as 'unclear' risk of bias for attrition bias.</P>
<P>The two most recent trials provided participant flow charts. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> explained any losses or exclusions. For <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>, one woman in the surgical management group requested and received medical (drug) management instead. Losses to follow up were 1/14 from expectant group and 1/12 from the surgical management group. In <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>, 356 of the 402 assigned to surgical treatment actually had curettage; 30 (8%) miscarried before admission and 16 (4%) declined to have curettage after randomization. However, participants were analyzed in the groups to which they were allocated, with the exception of a viable pregnancy in each of the comparison groups. Losses to follow up were 2.7% of the expectant group and 2.5% of surgical group.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2011-05-17 20:46:32 +0100" MODIFIED_BY="Laureen M Lopez">
<P>We did not detect any selective reporting; that is, all specific outcomes appeared to have been presented in the results. However, some of the shorter reports did not list the outcomes as specific objectives (<LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>). We cannot be certain whether other outcomes were assessed but not reported.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-02-07 10:07:47 +0000" MODIFIED_BY="Denise Atherton">
<P>Information on days of bleeding and pain came from participants' reports and diaries, which may have varied in consistency. Pregnancy and live births were also self-reported. However, under-reporting conception seems less likely for this type of trial than for a pregnancy-prevention study.</P>
<P>
<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> was rated as 'unclear' risk of 'other' bias. The report does not mention when follow-
up was obtained for most outcomes. Pregnancy was reported for the six-month timeframe.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-02-07 15:29:14 +0000" MODIFIED_BY="Denise Atherton">
<P>The review includes data from seven trials where expectant care was compared with surgical management in cases of miscarriages. The trials had a total of 1931 participants; 1521 were in the study arms included in this review. Two trials had another study arm that received medical management (<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>, N = 398; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>, N = 12). More than half of the participants in this review (N = 802) came from <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>.</P>
<P>We conducted sensitivity analysis by examining the meta-analyses that included <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>, due to the potential risk of bias related to inadequate randomization. The direction and general significance of the results was not substantially altered in any meta-analysis when <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was removed.</P>
<P>To enhance readability, this section emphasizes the important results. We present the risk ratio (RR), mean difference (MD) and confidence intervals (CI) for each meta-analysis, as well as the significant results (P &lt; 0.05) for other analyses. All of the results can be viewed in the tables and figures.</P>
<SUBSECTION>
<HEADING LEVEL="3">Incomplete miscarriage</HEADING>
<P>Five studies reported on retained products of conception, incomplete miscarriage, or spontaneous loss (<LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). The expectant-care group was significantly more likely to have retained products of conception or incomplete miscarriage by two weeks (RR 3.98; 95% CI 2.94 to 5.38; four trials, 1263 women; <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). The results were similar when assessed at six to eight weeks (RR 2.56; 95% CI 1.15 to 5.69; three trials, 430 women; <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). When <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was removed for sensitivity analysis, the results did not change substantively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical need for additional or unplanned surgery</HEADING>
<P>Five studies reported on the need for unplanned surgical treatment (<LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). The need was significantly greater for women in the expectant-care group when the studies were combined (RR 7.35; 95% CI 5.04 to 10.72; five trials, 1454 women; <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). This meta-analysis showed substantial heterogeneity (P value = 0.07; I² = 55%). We examined the results after removing <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>, which had unbalanced study arms with no explanation. <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was also unclear about the timeframe for this outcome. With the remaining four trials, the heterogeneity was moderate (P value = 0.20; I² = 36%), and the results were similar to those from the original analysis (RR 7.89; 95% CI 5.34 to 11.68; four trials, 1171 women; <LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>).</P>
<P>The percentages of women in the expectant-care group needing surgical management ranged from 2% to 44% with a mean of 28% (215/772). Within the surgical-treatment group, the percentages needing additional surgery ranged from zero to 5% with a mean of 4% (27/682). In <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>, 20 of the 103 expectant-care group needed surgical treatment by 14 days, and one had an operation on request. No women in the surgical group required additional operations. In <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>, seven of the 46 women in the observational group had surgical evacuation by 10 days. This was generally due to unacceptable pain or bleeding. <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> reported the need for surgical treatment in seven of the 64 expectant-care women by six weeks. An additional 25 had surgical intervention on request. <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> reported surgical treatment was needed for three of the 161 women in the expectant-care group. In <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>, 44% of the expectant-care group (177/398) had unplanned curettage, compared with 5% (22/402) of those with surgical management. About half of those women had the unplanned curettage before the 10- to 14-day visit, while the others had the additional treatment at the follow-up visit or later.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pelvic infection</HEADING>
<P>All seven studies reported the number of women with pelvic infection. Pelvic infection was similar between the study groups up to eight weeks (RR 0.63; 95% CI 0.36 to 1.12; seven trials, 1514 women;(<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). The proportions of women diagnosed with infection ranged from zero to 10%. Three trials reported no cases of pelvic infection in either study group (<LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). When <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was removed for sensitivity analysis, the results did not change substantively. The results were also examined without <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>, because the exact timeframe for assessment was not known, but the results did not change meaningfully.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Bleeding</HEADING>
<P>The reporting of bleeding complications varied across the seven studies. Bleeding was reported as mean number of days in <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK> and <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>. The expectant-care group had 1.59 (MD) more days of bleeding (95% CI 0.74 to 2.45; <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). In <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>, the amount of bleeding was also subjectively reported on a three-point 'scale'. Although means and standard deviations were provided, categorical data may have better represented such a measure, so we did not include those data. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> analyzed bleeding categorically (less than or equal to three days, four to eight days, and equal to or greater than nine days). The comparison groups were similar in the numbers with bleeding that lasted nine days or more (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
<P>Three trials reported bleeding with median numbers of days (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997;</LINK> <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> provided the ranges, and reported no significant difference. <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> gave the 25th and 75th (interquartile) percentiles. Both reported that the expectant-care group had significantly longer bleeding than the surgical-treatment group (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>): 17 versus 13 days for <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> and 12 versus eight days in <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>.</P>
<P>The need for transfusion was greater for the expectant care group, largely due to the seven women who needed transfusion in <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>. The risk ratio was (RR 6.45; 95% CI 1.21 to 34.42; three trials, 1205 women <LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> and <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> each had one woman in the expectant-care group who needed transfusion. The mean percentages needing transfusion were 1.4% in the expectant-care group (9/623) and zero in the surgical-management group (0/582). The risk of hemorrhage greater than 500 mL was not significantly different for the groups in <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>. The expectant-care group had two cases and the surgical-treatment group had one. When <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK> was removed for sensitivity analysis, the results did not change substantively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pain</HEADING>
<P>Six studies reported on pain, and the outcome measures varied here as well. Pain was reported as mean number of days in <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> and with a pain scale in <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>. No significant differences in pain emerged in <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>. The mean pain score was significantly greater for the expectant-care group in <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>, but the authors claimed the pain was usually mild to moderate. The MD was 0.70 (95% CI 0.30 to 1.10; <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). To assess pain, <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> used extra analgesic taken. The expectant-care group was more likely to use extra analgesic than the surgical-treatment group (RR 2.52; 95% CI 1.98 to 3.19, <LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). Three trials reported the days of pain as medians (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>). The comparison groups were similar for median days within those trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Costs and sick leave</HEADING>
<P>
<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> was the only trial with cost estimates. A secondary report examined hospital costs and the costs of "broader impacts," e.g., community care, travel costs, and lost productivity. Total costs were lower for expectant care than for surgical treatment. The MD (in UK pounds sterling) was -499.10 (95% CI -613.04 to -385.16; <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>).</P>
<P>Four studies reported days of sick leave or days to return to usual activities (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006)</LINK>. Measures included means, medians, and days categorized. <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> and <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> showed no significant differences between the two groups. <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> reported median numbers of days, but each noted that the study arms were similar.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Psychosocial outcomes</HEADING>
<P>Psychosocial outcomes were examined in four studies (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>; <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>). Measures included anxiety and depression, the SF-36 (short-form health survey with 36 questions), and participant satisfaction.</P>
<P>In <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>, the two study arms were similar for the anxiety inventory, as reported in the 1996 paper. This outcome was assessed in a smaller group of 86 women who spoke Swedish. Within the expectant management group, those who had complete miscarriage in three days had a similar mean anxiety score compared with those who had surgical treatment due to incomplete miscarriage. The trends were similar for the visual analogue items, but the results were described for the nine items individually and there was no overall score. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> used the Hospital Anxiety and Depression Scale (HADS) and the SF-36. The eight sub-scales of the SF-36 comprise the two summary measures of mental and physical health. The instruments were administered at both two and eight weeks. The eight-week assessments from <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> were used here, on the assumption that any differences at two weeks may not be clinically important. The researchers compared those with a HADS score of at least 11. The expectant-care and surgical-management groups were similar for all four scales in <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>, and reportedly also similar in <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>.</P>
<P>
<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> and <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> reported on women's satisfaction with their management. <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> provided no information on the measure used. Reportedly, all 19 women in the expectant-care group were satisfied with their conservative management, compared with 14 of 16 women with surgical management, due to the delays between diagnosis and operation. <LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK> asked the women if they would choose the same method of care again. The groups were similar in their responses. The results were examined without <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>, since the timeframe for assessment was not known, but the overall result did not change. Both studies had small samples.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Pregnancy or live births</HEADING>
<P>Future pregnancies or births were reported in <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> and <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>. Data were limited to the women who attempted pregnancy or who expressed the desire to become pregnant after the miscarriage. <LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK> reported pregnancies after management, and the study arms were similar. For <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>, a 2009 paper reported on pregnancies and live births after long-term follow-up. The response rate to the questionnaire was 68%. The overall pregnancy rate was reportedly 84%. Live births by five years were similar for the expectant-care and surgical-management groups. Time to subsequently giving birth was shown by study arm in a figure; the researchers reported the groups were similar. The researchers also reported that analysis of time to first pregnancy was similar to that for live births.</P>
<P>Two 1997 papers from <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> reported on pregnancy rates among women attempting conception up to 24 months. For those who returned questionnaires of those who wished to become pregnant, pregnancy rates were similar for the two study arms. However, information was insufficient to evaluate fertility after the miscarriage.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other outcomes</HEADING>
<P>There were limited data reported for other outcomes. <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK> noted only one case with cervical tear in the expectant-care group and no cases of uterine perforation. <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK> reported no perioperative complications in either group and no endometritis. <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK> listed the number of total complications and described each.</P>
<P>The trials did not specifically report data on our other primary outcomes of complications requiring hysterectomy, admission to intensive care unit, and death. Also, they did not mention the secondary outcome of intrauterine adhesions.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-02-07 15:26:51 +0000" MODIFIED_BY="Denise Atherton">
<SUMMARY_OF_RESULTS MODIFIED="2012-02-07 15:26:51 +0000" MODIFIED_BY="Denise Atherton">
<P>Miscarriage remains a common outcome of pregnancy, affecting millions of women annually. For generations, the management has been dictated by concerns about infection and hemorrhage, but the scientific basis for routine intervention was weak. Recent randomized controlled trials suggest that routine surgical evacuation has no clear superiority over expectant management. Although most of trials were of limited size and quality, one was good quality and adequately powered. These trials indicate no serious medical risks associated with watchful waiting until completion, with the exception of hemorrhage severe enough to require transfusion. No increased risk of infection was seen. Efficacy of antibiotics for treating pelvic infection was not available in the included studies. However, antibiotic prophylaxis for incomplete abortion has been reviewed elsewhere (<LINK REF="REF-May-2007" TYPE="REFERENCE">May 2007</LINK>).</P>
<P>The principal outcomes of interest were incomplete miscarriage and the need for surgical completion. These problems were more common in the expectant-care group than in the surgical group. However, because the outcome assessors were unlikely to have been blinded to treatment group, information bias may have influenced these results. Gynecologists accustomed to routine surgical evacuation may have readily recommended an operation when none was medically necessary. Early experience with medical abortion supports this hypothesis. Physicians inexperienced with medical abortion are more likely to intervene with surgical evacuation than are those experienced with a passive approach to completion. As experience with medical abortion grows, rates of surgical intervention decline (<LINK REF="REF-Cabezas-1998" TYPE="REFERENCE">Cabezas 1998</LINK>; <LINK REF="REF-Winikoff-1996" TYPE="REFERENCE">Winikoff 1996</LINK>).</P>
<P>Bleeding was more common with expectant management. Nine women needed blood transfusion of the 623 with expectant care and none of the 582 with surgical management. Hemorrhage can occur with miscarriage, and can be dangerous. Indeed, hemorrhage is the second most common cause of death related to miscarriage in the United States (<LINK REF="REF-Saraiya-1999" TYPE="REFERENCE">Saraiya 1999</LINK>). Prompt transport to a hospital with facilities for volume expansion and blood transfusion is important if heavy bleeding cannot be quickly controlled by medical or surgical means.</P>
<P>The cost of health care is an increasing concern, both for the patient and the healthcare system. <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> was the only study to examine the economic impact in a secondary paper. The costs for hospital care and broader impacts, such as travel costs and lost productivity, were significantly greater for surgical management.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-02-07 10:43:37 +0000" MODIFIED_BY="Denise Atherton">
<P>Since our original review, two trials were published that compared expectant management, medical management such as administration of misoprostol, and surgical evacuation. While one was substantially smaller than planned (<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>), the other was a large, good-quality trial (<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>).</P>
<P>When surgical evacuation is chosen in this setting, either manual vacuum aspiration or aspiration with an electric suction pump is appropriate. A systematic review of the two techniques found no major differences in the two approaches (<LINK REF="REF-Wen-2008" TYPE="REFERENCE">Wen 2008</LINK>). However, women tend to find the noise of the electric pump unsettling (<LINK REF="REF-Dean-2003" TYPE="REFERENCE">Dean 2003</LINK>).</P>
<P>The availability of medical (drug) management, for example with misoprostol, has added another important option for women with miscarriage (<LINK REF="REF-Blanchard-2004" TYPE="REFERENCE">Blanchard 2004</LINK>; <LINK REF="REF-Chen-2007" TYPE="REFERENCE">Chen 2007</LINK>; <LINK REF="REF-Graziosi-2004" TYPE="REFERENCE">Graziosi 2004</LINK>). Women no longer have to choose between an operation and doing nothing. Misoprostol can be given vaginally, orally, under the tongue, or against the cheek (<LINK REF="REF-Neilson-2006" TYPE="REFERENCE">Neilson 2006</LINK>; <LINK REF="REF-Neilson-2010" TYPE="REFERENCE">Neilson 2010</LINK>). Non-oral routes of administration appear more effective than oral. The optimal regimen of misoprostol remains unclear. Higher doses are associated with more prostaglandin side effects, including diarrhea and fever. We excluded studies of medical management for miscarriage, which is examined in other reviews (<LINK REF="REF-Neilson-2006" TYPE="REFERENCE">Neilson 2006</LINK>; <LINK REF="REF-Neilson-2010" TYPE="REFERENCE">Neilson 2010</LINK>).</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-02-07 11:10:13 +0000" MODIFIED_BY="Denise Atherton">
<P>All the studies were randomized controlled trials, and none had high losses to follow up. Most had no obvious risk of bias. However, information on study design and implementation was lacking for the earlier studies. One trial had unbalanced study arms, but removing that trial did not affect any of the important differences between the study arms.</P>
<P>We assessed the quality of evidence using the GRADE approach (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>; <LINK REF="TBL-02" TYPE="TABLE">Table 2</LINK>). The quality was considered to be moderate for our primary outcomes of incomplete miscarriage and need for additional or unplanned surgical evacuation; quality was high for the data on pelvic infection. For our secondary outcomes, the quality was moderate or low except for the cost results, which we considered high quality.</P>
</QUALITY_OF_EVIDENCE>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2011-05-17 21:45:20 +0100" MODIFIED_BY="Laureen M Lopez">
<IMPLICATIONS_PRACTICE MODIFIED="2011-05-17 21:45:20 +0100" MODIFIED_BY="Laureen M Lopez">
<P>The existing evidence does not indicate the superiority of either expectant care or surgical treatment. If women can accept a higher rate of incomplete miscarriage, need for later surgical evacuation, and need for blood transfusion, watchful waiting is a reasonable course of action. The policy of routine uterine evacuation lacks scientific support. Infection rates did not differ, although transfusion rates did. Costs were higher for surgical management. Given the evidence, women's preferences should play a large role in management plans.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2011-03-30 16:33:18 +0100" MODIFIED_BY="[Empty name]">
<P>One large trial of good quality compared expectant care with surgical management. Medical management was also examined in that trial and in another smaller one, but was not reviewed here. Several studies were underpowered. Studies evaluating expectant management without ultrasound examination would also be of interest. Lastly, studies need to separate outcomes for pregnancies found to be non-viable by ultrasound examination (without bleeding or pain).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-01-17 13:01:51 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Carol Manion of FHI 360 assisted with the computer literature searches.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-02-07 15:26:58 +0000" MODIFIED_BY="[Empty name]">
<P>Kavita Nanda and Alessandra Peloggia conceived the idea and registered the title. Kavita Nanda and Alessandra Peloggia drafted the review and did the primary data extraction for the initial review. David Grimes wrote parts of the review. Laureen Lopez updated the sources, did the secondary data extraction, and wrote sections of the review. Geeta Nanda edited the review to ensure that psychological and social issues were assessed appropriately. For the 2012 update, Laureen Lopez reviewed the search results, did the primary data extraction, and incorporated the new trials. David Grimes did the secondary data extraction and updated the <LINK TAG="BACKGROUND" TYPE="SECTION">Background</LINK> and <LINK TAG="DISCUSSION" TYPE="SECTION">Discussion</LINK>. All authors reviewed the manuscript.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2011-12-08 14:32:27 +0000" MODIFIED_BY="Laureen M Lopez">
<P>We updated the terminology of miscarriage to explain what the preferred term of 'early pregnancy failure' includes (Background, paragraph 2) . For consistency, we carried that updated terminology through the wording of the objective.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-02-07 09:31:56 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Chipchase-1997" MODIFIED="2011-02-03 13:55:18 +0000" MODIFIED_BY="Laureen M Lopez" NAME="Chipchase 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-01-26 19:21:23 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chipchase J, James D</AU>
<TI>Randomised trial of expectant versus surgical management of spontaneous miscarriage</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>104</VL>
<PG>840-1</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Karlsen-2001" MODIFIED="2011-02-03 13:55:27 +0000" MODIFIED_BY="Laureen M Lopez" NAME="Karlsen 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-01-26 21:19:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Karlsen JH, Schiotz HJ</AU>
<TI>After spontaneous abortion - surgical revision or not?</TI>
<TO>Utskrapning eller ikke etter spontanabort?</TO>
<SO>Tidsskrift for Den Norske Laegeforening</SO>
<YR>2001</YR>
<VL>121</VL>
<NO>24</NO>
<PG>2812-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Nielsen-1995" MODIFIED="2011-06-06 19:00:56 +0100" MODIFIED_BY="[Empty name]" NAME="Nielsen 1995" YEAR="1995">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Blohm F, Hahlin M, Nielsen S, Milsom I</AU>
<TI>Fertility after a randomised trial of spontaneous abortion managed by surgical evacuation or expectant treatment [letter]</TI>
<SO>Lancet</SO>
<YR>1997</YR>
<VL>349</VL>
<PG>995</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen S, Hahlin M, Moller A, Granberg S</AU>
<TI>Bereavement, grieving and psychological morbidity after first trimester spontaneous abortion: comparing expectant management with surgical evacuation</TI>
<SO>Human Reproduction</SO>
<YR>1996</YR>
<VL>11</VL>
<NO>8</NO>
<PG>1767-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 19:00:56 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="BOOK_SECTION">
<AU>Nielsen S, Hahlin M</AU>
<TI>Expectant management of first-trimester miscarriage</TI>
<SO>Problems in Early Pregnancy - Advances in Diagnosis and Management</SO>
<YR>1997</YR>
<PG>265-76</PG>
<ED>Grundzinkas JG</ED>
<PB>Royal College of Obstetricians and Gynaecologists</PB>
<CY>London</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Nielsen S, Hahlin M</AU>
<TI>Expectant management of first-trimester spontaneous abortion</TI>
<SO>Lancet</SO>
<YR>1995</YR>
<VL>345</VL>
<PG>84-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shelley-2005" MODIFIED="2011-01-25 17:54:24 +0000" MODIFIED_BY="Laureen M Lopez" NAME="Shelley 2005" YEAR="2005">
<REFERENCE MODIFIED="2011-01-25 17:54:24 +0000" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Shelley JM, Healy D, Grover S</AU>
<TI>A randomised trial of surgical, medical and expectant management of first trimester spontaneous miscarriage</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>2005</YR>
<VL>45</VL>
<PG>122-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Thong-2002" MODIFIED="2011-02-03 13:54:25 +0000" MODIFIED_BY="Laureen M Lopez" NAME="Thong 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="OTHER">
<AU>Thong KJ, Mahmood TA, Shehata KI</AU>
<TI>A randomised trial comparing conservative management versus surgical uterine evacuation for first trimester miscarriage with retained products of conception</TI>
<SO>www.show.scot.nhs.uk/cso/Publications/ExecSumms/Oct_Nov02.htm</SO>
<YR>(accessed 03 March 2005)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trinder-2006" MODIFIED="2012-02-07 09:31:56 +0000" MODIFIED_BY="[Empty name]" NAME="Trinder 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-02-07 09:31:56 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrou S, Trinder J, Brocklehurst P, Smith L</AU>
<TI>Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2006</YR>
<VL>113</VL>
<NO>8</NO>
<PG>879-89</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 19:05:15 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith LFP, Ewings PD, Quinlan C</AU>
<TI>Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial</TI>
<SO>BMJ</SO>
<YR>2009</YR>
<VL>339</VL>
<PG>b3827</PG>
<IDENTIFIERS MODIFIED="2011-06-06 19:05:15 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-06-06 19:05:13 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1136/bmj.b3827"/>
<IDENTIFIER MODIFIED="2011-06-06 19:05:15 +0100" MODIFIED_BY="[Empty name]" TYPE="PUBMED" VALUE="19815581"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE MODIFIED="2011-01-26 19:03:44 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L</AU>
<TI>Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial)</TI>
<SO>BMJ</SO>
<YR>2006</YR>
<VL>332</VL>
<NO>7552</NO>
<PG>1235-40</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="SOUGHT" ID="STD-Wieringa_x002d_de-Waard-2002a" MODIFIED="2011-06-30 11:04:23 +0100" MODIFIED_BY="[Empty name]" NAME="Wieringa-de Waard 2002a" YEAR="2002">
<REFERENCE MODIFIED="2011-06-30 10:52:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wieringa-De Waard M, Ankum W</AU>
<TI>The management of miscarriage: conservative management or curettage?</TI>
<TO>Het beleid bij een miskraam: afwachten of curettage?</TO>
<SO>Tijdschrift voor Fertiliteitsonderzoek</SO>
<YR>2004</YR>
<VL>18</VL>
<NO>1</NO>
<PG>8-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-30 10:58:43 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Wieringa-de Waard M, Vos J, Bonsel G, Bindels P, Ankum W. Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Human Reproduction 2002;17(9):2445-50&lt;/p&gt;" NOTES_MODIFIED="2011-06-30 10:58:43 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Wieringa-de Waard M, Vos J, Bonsel G, Bindels P, Ankum W</AU>
<TI>Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>2445-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2011-06-30 10:56:45 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2011-06-30 11:04:29 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gazvani-2000" NAME="Gazvani 2000" YEAR="2000">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gazvani R, Templeton A</AU>
<TI>A pilot study for the use of manual vacuum aspiration in early pregnancy loss [abstract]</TI>
<SO>Journal of Obstetrics and Gynaecology</SO>
<YR>2000</YR>
<VL>20</VL>
<PG>105</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gronlund-2002" NAME="Gronlund 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gronlund L, Gronlund AL, Clevin L, Anderssen B, Palmgren N, Lidegaard O</AU>
<TI>Spontaneous abortion: expectant management, medical treatment or surgical evacuation</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>2002</YR>
<VL>81</VL>
<PG>781-2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leung-2004" NAME="Leung 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leung SW, Pang MW, Chung TKH</AU>
<TI>Retained products of gestation in miscarriage: an evaluation of transvaginal ultrasound criteria for diagnosing an "empty uterus"</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>191</VL>
<PG>1133-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Ogden-2001" MODIFIED="2011-06-06 19:06:09 +0100" MODIFIED_BY="[Empty name]" NAME="Ogden 2001" YEAR="2001">
<REFERENCE MODIFIED="2011-06-06 19:06:09 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>Ogden J</AU>
<TI>A pragmatic randomised control trial of expectant versus surgical management of first trimester spontaneous miscarriage</TI>
<SO>National Research Register 2001 (http://www.nrr.nhs.uk/)</SO>
<YR>(accessed 25 February 2001)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schwarzler-2003" MODIFIED="2011-01-25 18:58:20 +0000" MODIFIED_BY="Laureen M Lopez" NAME="Schwarzler 2003" YEAR="2003">
<REFERENCE MODIFIED="2011-01-25 18:58:20 +0000" MODIFIED_BY="Laureen M Lopez" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schwarzler P</AU>
<TI>The conservative management of first trimester miscarriages and the use of sonography for patients' selection [abstract]</TI>
<SO>Ultrasound in Obstetrics and Gynecology</SO>
<YR>2003</YR>
<VL>22</VL>
<NO>Suppl 1</NO>
<PG>4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Shehata-2000" MODIFIED="2011-06-06 19:07:40 +0100" MODIFIED_BY="[Empty name]" NAME="Shehata 2000" YEAR="2000">
<REFERENCE MODIFIED="2011-06-06 19:07:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Mahmood TA, Shehata KI, Thong KJ. A randomized study of conservative management versus surgical uterine evacuation for incomplete miscarriage&lt;/p&gt;" NOTES_MODIFIED="2011-06-06 19:07:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Mahmood TA, Shehata KI, Thong KJ</AU>
<TI>A randomized study of conservative management versus surgical uterine evacuation for incomplete miscarriage (Interim analysis) [abstract]</TI>
<SO>XVI FIGO World Congress of Obstetrics &amp; Gynecology (Book 3); 2000 Sept 3-8; Washington DC</SO>
<YR>2000</YR>
<PG>68-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2011-06-06 19:07:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Shehata KI, Thong KJ, Mahmood TA</AU>
<TI>Interim results of a random allocation study of conservative management versus uterine evacuation for incomplete miscarriage [abstract]</TI>
<SO>Journal of Obstetrics and Gynaecology</SO>
<YR>2000</YR>
<VL>20</VL>
<NO>1</NO>
<PG>105-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-2006" MODIFIED="2011-01-26 19:04:57 +0000" MODIFIED_BY="[Empty name]" NAME="Smith 2006" YEAR="2006">
<REFERENCE MODIFIED="2011-01-26 19:04:57 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith LF, Frost J, Levitas R, Bradley H, Garcia J</AU>
<TI>Women's experiences of three early miscarriage management options: a qualitative study</TI>
<SO>British Journal of General Practice</SO>
<YR>2006</YR>
<VL>56</VL>
<NO>524</NO>
<PG>198-205</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ulstrup-1997" NAME="Ulstrup 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ulstrup KS, Lopez HBB, Mogensen H, Blaakaer J</AU>
<TI>Treatment of early spontaneous abortion. Evacuation or expectation?</TI>
<SO>Acta Obstetricia et Gynecologica Scandinavica</SO>
<YR>1997</YR>
<VL>76 Suppl</VL>
<NO>167:1</NO>
<PG>78</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wieringa_x002d_de-Waard-2002b" MODIFIED="2011-06-30 11:03:25 +0100" MODIFIED_BY="[Empty name]" NAME="Wieringa-de Waard 2002b" YEAR="2002">
<REFERENCE MODIFIED="2011-06-30 11:03:25 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wieringa-de Waard M, Hartman EE, Ankum WM, Reitsma JB, Bindels PJE, Bonsel GJ</AU>
<TI>Expectant management versus surgical evacuation in first trimester miscarriage: health-related quality of life in randomized and non-randomized patients</TI>
<SO>Human Reproduction</SO>
<YR>2002</YR>
<VL>17</VL>
<PG>1638-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wieringa_x002d_de-Waard-2004a" MODIFIED="2011-06-30 11:04:23 +0100" MODIFIED_BY="[Empty name]" NAME="Wieringa-de Waard 2004a" YEAR="2004">
<REFERENCE MODIFIED="2011-06-30 11:04:23 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wieringa-de Waard M, Bindels PJE, Vos J, Bonsel GJ, Stalmeier PFM, Ankum WM</AU>
<TI>Patient preferences for expectant management vs. surgical evacuation in first-trimester uncomplicated miscarriage</TI>
<SO>Journal of Clinical Epidemiology</SO>
<YR>2004</YR>
<VL>57</VL>
<PG>167-73</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="Laureen M Lopez">
<STUDY DATA_SOURCE="PUB" ID="STD-Wijesinghe-2011" MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="[Empty name]" NAME="Wijesinghe 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wijesinghe PS, Padumadasa GS, Palihawadana TS, Marleen FS</AU>
<TI>A trial of expectant management in incomplete miscarriage</TI>
<SO>Ceylon Medical Journal</SO>
<YR>2011</YR>
<VL>56</VL>
<NO>1</NO>
<PG>10-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES MODIFIED="2011-01-25 18:58:20 +0000" MODIFIED_BY="Laureen M Lopez"/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-02-07 09:31:34 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-02-07 09:31:34 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Alderson-2004" NAME="Alderson 2004" TYPE="OTHER">
<AU>Alderson P, Green S, Higgins JPT, editors</AU>
<TI>Cochrane Reviewers' Handbook 4.2.2 [updated March 2004]</TI>
<SO>In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley &amp; Sons, Ltd</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ballagh-1998" NAME="Ballagh 1998" TYPE="JOURNAL_ARTICLE">
<AU>Ballagh SA, Harris HA, Demasio K</AU>
<TI>Is curettage needed for uncomplicated incomplete spontaneous abortion?</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>179</VL>
<PG>1279-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Blanchard-2004" NAME="Blanchard 2004" TYPE="JOURNAL_ARTICLE">
<AU>Blanchard K, Taneepanichskul S, Kiriwat O, Sirimai K, Svirirojana N, Mavimbele N, et al</AU>
<TI>Two regimens of misoprostol for treatment of incomplete abortion</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2004</YR>
<VL>103</VL>
<PG>860-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Cabezas-1998" NAME="Cabezas 1998" TYPE="JOURNAL_ARTICLE">
<AU>Cabezas E</AU>
<TI>Medical versus surgical abortion</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>1998</YR>
<VL>63</VL>
<PG>S141-S146</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Chen-2007" MODIFIED="2011-03-29 21:34:21 +0100" MODIFIED_BY="[Empty name]" NAME="Chen 2007" TYPE="JOURNAL_ARTICLE">
<AU>Chen BA, Creinin MD</AU>
<TI>Contemporary management of early pregnancy failure</TI>
<SO>Clinical Obstetrics and Gynecology</SO>
<YR>2007</YR>
<VL>50</VL>
<PG>67-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conway-2000" NAME="Conway 2000" TYPE="JOURNAL_ARTICLE">
<AU>Conway K, Russell G</AU>
<TI>Couples' grief and experience of support in the aftermath of miscarriage</TI>
<SO>British Journal of Medical Psychology</SO>
<YR>2000</YR>
<VL>73</VL>
<PG>531-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dalton-2009" MODIFIED="2011-03-30 19:51:04 +0100" MODIFIED_BY="[Empty name]" NAME="Dalton 2009" TYPE="JOURNAL_ARTICLE">
<AU>Dalton VK, Harris LH, Clark SJ, Cohn L, Guire K, Fendrick AM</AU>
<TI>Treatment patterns for early pregnancy failure in Michigan</TI>
<SO>Journal of Women's Health</SO>
<YR>2009</YR>
<VL>18</VL>
<PG>787-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Dean-2003" MODIFIED="2012-02-07 09:29:17 +0000" MODIFIED_BY="[Empty name]" NAME="Dean 2003" TYPE="OTHER">
<AU>Dean G, Cardenas L, Darney P, Goldberg A</AU>
<TI>Acceptability of manual versus electric aspiration for first trimester abortion: a randomized trial</TI>
<SO>Contraception</SO>
<YR>2003</YR>
<VL>67</VL>
<NO>3</NO>
<PG>201-6</PG>
<EN>2003/03/06</EN>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Geller-2001" NAME="Geller 2001" TYPE="JOURNAL_ARTICLE">
<AU>Geller PA, Klier CM, Neugebauer R</AU>
<TI>Anxiety disorders following miscarriage</TI>
<SO>Journal of Clinical Psychiatry</SO>
<YR>2001</YR>
<VL>62</VL>
<PG>432-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Graziosi-2004" NAME="Graziosi 2004" TYPE="JOURNAL_ARTICLE">
<AU>Graziosi GCM, Mol BW, Ankum WM, Bruinse HW</AU>
<TI>Management of early pregnancy loss</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2004</YR>
<VL>86</VL>
<PG>337-46</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hemminki-1998" NAME="Hemminki 1998" TYPE="JOURNAL_ARTICLE">
<AU>Hemminki E</AU>
<TI>Treatment of miscarriage: current practice and rationale</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1998</YR>
<VL>91</VL>
<PG>247-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2011-06-06 19:00:13 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-May-2007" MODIFIED="2011-01-26 19:27:13 +0000" MODIFIED_BY="[Empty name]" NAME="May 2007" TYPE="COCHRANE_REVIEW">
<AU>May W, Gülmezoglu AM, Ba-Thike K</AU>
<TI>Antibiotics for incomplete abortion</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2007</YR>
<NO>4</NO>
<IDENTIFIERS MODIFIED="2011-01-26 19:27:13 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-01-26 19:27:13 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD001779.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Moher-2001" NAME="Moher 2001" TYPE="JOURNAL_ARTICLE">
<AU>Moher D, Schulz KF, Altman DG, Lepage L</AU>
<TI>The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials</TI>
<SO>Lancet</SO>
<YR>2001</YR>
<VL>357</VL>
<PG>1191-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Molnar-2000" NAME="Molnar 2000" TYPE="JOURNAL_ARTICLE">
<AU>Molnar AM, Oliver LM, Geyman JP</AU>
<TI>Patient preferences for management of first-trimester incomplete spontaneous abortion</TI>
<SO>Journal of the American Board of Family Practice</SO>
<YR>2000</YR>
<VL>13</VL>
<PG>333-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2006" MODIFIED="2011-05-17 20:23:34 +0100" MODIFIED_BY="Laureen M Lopez" NAME="Neilson 2006" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP, Hickey M, Vazquez JC</AU>
<TI>Medical treatment for early fetal death (less than 24 weeks)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2006</YR>
<NO>3</NO>
<IDENTIFIERS MODIFIED="2011-05-17 20:23:34 +0100" MODIFIED_BY="Laureen M Lopez">
<IDENTIFIER MODIFIED="2011-05-17 20:23:34 +0100" MODIFIED_BY="Laureen M Lopez" TYPE="DOI" VALUE="10.1002/14651858.CD002253.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neilson-2010" MODIFIED="2011-05-23 19:22:23 +0100" MODIFIED_BY="[Empty name]" NAME="Neilson 2010" TYPE="COCHRANE_REVIEW">
<AU>Neilson JP, Gyte GML, Hickey M, Vazquez JC, Dou L</AU>
<TI>Medical treatments for incomplete miscarriage (less than 24 weeks)</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-05-23 19:22:23 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-05-23 19:22:23 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD007223.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Neugebauer-1997" MODIFIED="2012-02-07 09:30:11 +0000" MODIFIED_BY="Heather Maxwell" NAME="Neugebauer 1997" TYPE="JOURNAL_ARTICLE">
<AU>Neugebauer R, Kline J, Shrout P, Skodol A, O'Connor P, Geller PA, et al</AU>
<TI>Major depressive disorder in the 6 months after miscarriage</TI>
<SO>JAMA</SO>
<YR>1997</YR>
<VL>277</VL>
<PG>383-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2003" NAME="RevMan 2003" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2003</YR>
<EN>4.2 for Windows</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2011" MODIFIED="2011-06-06 19:11:44 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2011" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2011</YR>
<EN>5.1</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Saraiya-1999" NAME="Saraiya 1999" TYPE="JOURNAL_ARTICLE">
<AU>Saraiya M, Green CA, Berg CJ, Hopkins FW, Koonin LM, Atrash HK</AU>
<TI>Spontaneous abortion-related deaths among women in the United States -- 1981-1991</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1999</YR>
<VL>94</VL>
<PG>172-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sharma-1993" NAME="Sharma 1993" TYPE="JOURNAL_ARTICLE">
<AU>Sharma JB</AU>
<TI>Medical management of miscarriage. Psychological impact underestimated</TI>
<SO>BMJ</SO>
<YR>1993</YR>
<VL>306</VL>
<PG>1540</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sotiriadis-2005" MODIFIED="2011-06-06 18:57:26 +0100" MODIFIED_BY="[Empty name]" NAME="Sotiriadis 2005" TYPE="JOURNAL_ARTICLE">
<AU>Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP</AU>
<TI>Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2005</YR>
<VL>105</VL>
<NO>5 Pt 1</NO>
<PG>1104-13</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Wen-2008" MODIFIED="2012-02-07 09:31:34 +0000" MODIFIED_BY="[Empty name]" NAME="Wen 2008" TYPE="OTHER">
<AU>Wen J, Cai QY, Deng F, Li YP</AU>
<TI>Manual versus electric vacuum aspiration for first-trimester abortion: a systematic review</TI>
<SO>BJOG: an international journal of obstetrics and gynaecology</SO>
<YR>2008</YR>
<VL>115</VL>
<NO>1</NO>
<PG>5-13</PG>
<EN>2007/12/07</EN>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-WHO-2003" MODIFIED="2011-06-06 19:12:11 +0100" MODIFIED_BY="[Empty name]" NAME="WHO 2003" TYPE="BOOK">
<AU>WHO</AU>
<SO>Safe Abortion: technical and policy guidance for health systems</SO>
<YR>2003</YR>
<PB>World Health Organization</PB>
<CY>Geneva</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Winikoff-1996" NAME="Winikoff 1996" TYPE="JOURNAL_ARTICLE">
<AU>Winikoff B, Ellertson C, Clark S</AU>
<TI>Analysis of failure in medical abortion</TI>
<SO>Contraception</SO>
<YR>1996</YR>
<VL>54</VL>
<PG>323-7</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES/>
<PENDING_REFERENCES MODIFIED="2012-01-11 16:45:42 +0000" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="Denise Atherton">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-02-07 11:10:36 +0000" MODIFIED_BY="Denise Atherton" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2011-12-08 15:20:01 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Chipchase-1997">
<CHAR_METHODS MODIFIED="2011-12-08 15:20:01 +0000" MODIFIED_BY="Denise Atherton">
<P>Randomized controlled trial.<BR/>Report provided no a priori hypothesis or sample size and power calculation.<BR/>Women were assessed at 1 week, 2 weeks, and 6 months after inclusion.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>35 women with retained products of conception after spontaneous miscarriage.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-15 16:57:57 +0100" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 19) or surgical evacuation (N = 16).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-01-28 20:04:06 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Number of days of pain, vaginal bleeding, that normal daily routine was disrupted (sick leave); time taken for next normal period to occur, any treatment for complications, time taken for the next spontaneous pregnancy (number conceived by 6 months of those who attempted) and participants' satisfaction (number satisfied).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-07-01 14:10:33 +0100" MODIFIED_BY="[Empty name]">
<P>Attempts to contact the researcher for additional data were unsuccessful.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-15 16:58:38 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Karlsen-2001">
<CHAR_METHODS MODIFIED="2011-01-25 21:22:29 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Randomized controlled trial. <BR/>Women were assessed at 7 to 10 days and were offered another appointment if desired.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-01-28 17:31:27 +0000" MODIFIED_BY="Laureen M Lopez">
<P>97 women with first trimester spontaneous miscarriage. Excluded women with &gt; 12 weeks amenorrhea, &gt; 20 mm residual volume of tissue in uterus by ultrasound, unacceptable pain or bleeding.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-15 16:58:38 +0100" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 48) or surgical evacuation (N = 46).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Need for (additional) surgical treatment, operative complications, endometritis, number of days of bleeding, amount of bleeding (scale), pain (scale), unscheduled consultation.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-02-03 13:58:50 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Researcher provided additional data on request (means and standard deviations for days of bleeding, bleeding scale, and pain scale). However, we used the reported results in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-07 10:48:51 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Nielsen-1995">
<CHAR_METHODS MODIFIED="2011-08-15 16:58:54 +0100" MODIFIED_BY="Denise Atherton">
<P>Randomized controlled trial at 1 hospital.<BR/>Report did not contain an a priori hypothesis or sample size and power calculation.<BR/>Assessments done at 3 days and 14 days.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-07 10:48:51 +0000" MODIFIED_BY="[Empty name]">
<P>155 women in Sweden with inevitable or incomplete miscarriage; 86 of the 155 women participated in the survey on psychological outcomes. </P>
<P>Questionnaire was given to all women randomized starting August 1993 (about half-way through the study).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-12-08 16:29:18 +0000" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 103)</P>
<P>Surgical treatment (dilation and curettage) (N = 52).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-05-17 21:33:56 +0100" MODIFIED_BY="Laureen M Lopez">
<P>For 155 women: number of days with pain, number of days with vaginal bleeding, convalescence time, and complications, in particular, pelvic infection.<BR/>Secondary paper with 86 women who spoke Swedish: visual analog scales (9 items) regarding miscarriage, the present situation, and worries about future pregnancies.<BR/>Spielberger State Anxiety Inventory had 30 adjectives regarding affective states.<BR/>Later paper reported on subsequent conceptions.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-25 19:38:31 +0000" MODIFIED_BY="Laureen M Lopez"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-12-08 16:28:57 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Shelley-2005">
<CHAR_METHODS MODIFIED="2011-07-01 14:11:14 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial with 5 participating hospitals.<BR/>Sample size calculation based on 80% power to detect 5% difference in successful evacuation (see Notes below).<BR/>Assessments done at 10- to 14-day visits and at 8 weeks.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-08-16 11:18:51 +0100" MODIFIED_BY="Denise Atherton">
<P>39 women with inevitable or incomplete first trimester miscarriage.<BR/>Inclusion criteria: gestational age &lt;= 13 weeks, bleeding not excessive, stable hemodynamic system, temperature &lt;= 37.5°C, no serious systemic medical or surgical condition, use of prostaglandins not contraindicated, &gt;= 18 years old, not taking anticoagulants or oral corticosteroids, singleton pregnancy, no intrauterine device, and English sufficient for written questionnaire.<BR/>Exclusion criteria: non-viable intrauterine pregnancy on ultrasound but no vaginal bleeding.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-12-08 16:28:57 +0000" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 15) given contact phone number and information sheet with expected symptoms/signs and indications that care was required.<BR/>Surgical management (N = 12) by aspiration curettage or by dilation and curettage, depending on hospital and practitioner.<BR/>Medical intervention (N = 12) not addressed in this review.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-12-08 16:17:54 +0000" MODIFIED_BY="[Empty name]">
<P>Primary: effective evacuation of uterus without unplanned surgical evacuation.<BR/>Secondary: infection, hemorrhage, pain, bleeding, physical and emotional recovery (SF-36<SUP>1</SUP>), anxiety and depression from the Hospital Anxiety and Depression Scale.<BR/>Questionnaire completed at 10- to 14-day visit to hospital or local physician; second questionnaire mailed at 8 weeks.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-31 21:12:52 +0000" MODIFIED_BY="[Empty name]">
<P>Randomized: 12 surgical, 15 expectant, 12 medical.<BR/>Study was planned to be much larger (sample size 831). Recruitment was stopped after 1.5 years. Less than 50% eligible women were approached to participate, and 22% of those agreed to be randomized.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2011-08-16 11:19:49 +0100" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Thong-2002">
<CHAR_METHODS MODIFIED="2011-07-01 14:11:45 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial.<BR/>Assessments were done up to 14 days. Expectant care was extended by additional 5 weeks to assess outcome of miscarriage.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-07-01 14:11:47 +0100" MODIFIED_BY="[Empty name]">
<P>283 women with incomplete miscarriage or non-viable pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-16 11:19:49 +0100" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 161) versus surgical management (curettage) (N = 122).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Completion of miscarriage within two and seven weeks, pelvic infection, need for repeat curettage or suction evacuation due to heavy vaginal bleeding, blood transfusion needed.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-28 17:53:59 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Another 85 women, managed according to their choice, not included in analysis.<BR/>Abstract only available. Attempts to contact authors regarding full report were unsuccessful.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-07 10:51:46 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Trinder-2006">
<CHAR_METHODS MODIFIED="2011-07-01 14:12:33 +0100" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trial with 7 participating hospitals.<BR/>Sample size calculation based on 80% power to detect 50% lower incidence of primary outcome in surgical group versus expectant or medical management group.<BR/>Assessments done at 10- to 14-day visits and at 8 weeks.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-02-07 10:51:46 +0000" MODIFIED_BY="Denise Atherton">
<P>1200 women with incomplete miscarriage or early fetal or embryonic demise (&lt; 13 weeks gestation).<BR/>Exclusion criteria: severe hemorrhage or pain, pyrexia above 37.5°C, severe asthma, hemolytic disease or blood dyscrasias, current anticoagulation or systemic corticosteroid treatment, twin or higher order pregnancy, smoker aged &gt; 35 years, and inability to understand written English.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-16 11:20:22 +0100" MODIFIED_BY="Denise Atherton">
<P>All women received information sheet, 30 co-dydramol tablets, and emergency phone number.<BR/>Expectant management (N = 399).<BR/>Surgical management (N = 403) by suction curettage.<BR/>Medical management (N = 398) not addressed in this review.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2011-12-08 16:20:14 +0000" MODIFIED_BY="[Empty name]">
<P>Primary: documented gynecological infection within 14 days.<BR/>Secondary: treatment with antibiotics for presumed gynecological infection within 14 days and within 8 weeks; duration of clinical symptoms (pain, additional analgesia, vaginal bleeding, days off work, days before return to usual daily activities); complications (fall in hemoglobin at 10 to 14 days, blood transfusion, unplanned consultations or admissions within 14 days and within 8 weeks); efficacy&#8212;no unplanned surgical curettage within 8 weeks; psychological outcomes (depression and anxiety on the Hospital Anxiety and Depression Scale at 8 weeks); and return to normal activity (standard UK SF-36<SUP>2</SUP>).<BR/>Secondary papers reported on 1) live births by 5 years; 2) costs during first 8 weeks.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-01-25 20:23:09 +0000" MODIFIED_BY="Laureen M Lopez">
<P>Planned sample size was 1422. Due to slow recruitment, even with additional 33 months of recruitment, 1200 were randomized (expectant 399, surgical 403, medical 398).</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-02-07 10:53:55 +0000" MODIFIED_BY="Denise Atherton" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<CHAR_METHODS MODIFIED="2011-08-16 11:20:55 +0100" MODIFIED_BY="Denise Atherton">
<P>Randomized controlled trial in 2 hospitals.<BR/>Sample size to detect a difference of 20% in efficacy with 80% power; no alpha mentioned; had 162 total.<BR/>Women were assessed at bi-weekly visits for up to 3 months.<BR/>Success of intervention was assessed at 6 weeks.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>122 women with diagnosis of early fetal demise or incomplete miscarriage at &lt; 16 weeks. Excluded women under 18 years; those with severe bleeding, pain, or fever; and those who could not understand Dutch or English.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-08-16 11:21:08 +0100" MODIFIED_BY="Denise Atherton">
<P>Expectant care (N = 64) or suction curettage (N = 58).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-02-07 10:53:20 +0000" MODIFIED_BY="[Empty name]">
<P>Complications: excessive bleeding (&gt; 500 mL), genital infection, cervical tear, uterine perforation, intrauterine synechiae.<BR/>Efficacy: completion of miscarriage within 6 weeks (for expectant group) or no need for repeat curettage within 6 weeks (for surgical group).<BR/>Duration of symptoms: self-reported days of bleeding and pain, emergency curettage.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-02-07 10:53:55 +0000" MODIFIED_BY="Denise Atherton">
<P>Of 427 eligible women, 122 agreed to be randomized.<BR/>305 women expressed preference for treatment and were included in observational arm of study.<BR/>Researcher provided additional means and standard deviations on request. However, we used the reported medians in this review.</P>
<P>Additional report identified: <LINK REF="STD-Wieringa_x002d_de-Waard-2002b" TYPE="STUDY">Wieringa-de Waard 2002b</LINK> - secondary paper presenting same data on mental health as a figure. Another figure showed women randomized versus those who chose intervention.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>
<SUP>1</SUP> Reference cites the MOS (Medical Outcomes Study) 36-item short-form health survey (SF-36)<BR/>
<SUP>2</SUP> May be Short Form 36 Health Survey noted above, but the authors do not specify</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-02-07 10:55:43 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Gazvani-2000">
<CHAR_REASON_FOR_EXCLUSION>
<P>This abstract has insufficient data for analysis. Wrote to Dr Gazvani. A 2004 publication reports on manual vacuum aspiration but has no comparison data or any data on expectant care.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-07-01 14:13:31 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gronlund-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-07-01 14:13:31 +0100" MODIFIED_BY="[Empty name]">
<P>Observational study - not a RCT.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Leung-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>This trial did not meet the eligibility criteria for the review. All women were treated with misoprostol before randomization, and this review excludes medical management.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ogden-2001">
<CHAR_REASON_FOR_EXCLUSION>
<P>Studied failed, according to investigator (2004). There were no trial data. Women did not want to be randomized, since study did not offer more than usual practice.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-04-04 19:55:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Schwarzler-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-04-04 19:55:23 +0100" MODIFIED_BY="[Empty name]">
<P>Abstract did not provide comparative data (104 randomized: 48 D&amp;C; 56 conservative management). In 2004, researcher was going to write up the report. In Jan 2011, no relevant publication found in MEDLINE nor any papers for Schwarzler after 2005.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-20 21:19:07 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Shehata-2000">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-20 21:19:07 +0000" MODIFIED_BY="[Empty name]">
<P>Abstract was interim. There were no outcome data. Wrote to Dr Mahmood, but he had not yet written the report. Later found <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>, which may be related, but the sample sizes differed, as this abstract was interim. Wrote to Dr Thong, but did not receive a reply. Did not locate Dr Shehata.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-01-26 19:15:05 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-2006">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-01-26 19:15:05 +0000" MODIFIED_BY="[Empty name]">
<P>Qualitative study with sub-sample of 56 participants from <LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK> plus 16 non-participants.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Ulstrup-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>This abstract did not provide outcome data. Attempted (unsuccessfully) to contact Dr Ulstrup and the 3 co-authors. Also wrote to a co-author on another recent paper, but did not receive a reply.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-02-07 10:55:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002b">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-02-07 10:55:43 +0000" MODIFIED_BY="[Empty name]">
<P>Related to <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>. However, in this report, it was not possible to separate the 39% of those randomized to expectant management who later chose to undergo surgical treatment. The authors noted they analyzed by intention-to-treat. Mixing the two subgroups may have led to more favorable results that were not associated with the study arm. It could also have led to more variability in the data that masked a potential effect.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Wieringa_x002d_de-Waard-2004a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Follow-up study of RCT with different comparisons. Of the 122 randomized, 55 responded to a follow-up survey. They were compared with 81 women who chose not to be randomized.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>RCT: randomized controlled trial</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2012-02-09 13:45:27 +0000" MODIFIED_BY="Laureen M Lopez" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR STUDY_ID="STD-Wijesinghe-2011">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES/>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2011-02-02 17:49:12 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-02-07 11:10:36 +0000" MODIFIED_BY="Denise Atherton">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-02-07 10:50:21 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-30 11:11:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:10:48 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-08 16:09:52 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>No information other than allocation was 2:1 (expectant versus surgical).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-07 10:50:21 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>Generated by co-ordinating center using biased coin method of maintaining balance between study arms; stratified by hospital and gestation (&lt;= 7 weeks, 8 to 20 weeks, 11 to 13 weeks).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-08 14:43:30 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>Of the 283 randomized, 161 (57%) were managed conservatively and 122 (43%) surgically. No information provided on whether there was some crossover from assigned to actual group.<BR/>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-25 20:12:58 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>Central telephone system; minimization for comparability regarding center, miscarriage type, and gestation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-25 19:34:23 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>Attending physician used central electronic randomization; stratified for referral setting and gestational age.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2011-07-01 14:13:18 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-06-30 11:11:17 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-01 17:52:25 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>Groups randomized by choosing a sealed envelope.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:11:07 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>Sealed envelopes were withdrawn from a box.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-25 19:12:45 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>Centralized computer-based service via telephone 24 hours.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:12:26 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:12:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>Central telephone system.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:13:18 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>Central electronic randomization.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-11-28 16:23:46 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-06-30 11:11:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-01 14:10:50 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-01 14:11:08 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-11-28 16:23:46 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>Data analyst had access to unblinded data but no participant contact. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-01 14:12:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-01 14:12:58 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>None mentioned.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2011-07-01 14:13:18 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>No information.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-02-07 11:10:36 +0000" MODIFIED_BY="Denise Atherton" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-28 17:47:24 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>All women randomized were apparently included in the analysis. No mention of losses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-07 11:10:23 +0000" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>3 women (3%) excluded from analysis: 1 withdrew, 1 had ectopic pregnancy, and 1 was lost to follow up. Report did not specify to which group these women had been allocated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-31 20:56:21 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>Analysis appears to have included all women randomized. No mention of losses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-07 11:10:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>Participant flow chart provided. Lost to follow up at 8 weeks: expectant 1/14 (7%); surgical 1/12 (8%). Of surgical management group, 1 requested and received medical management instead.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-26 20:27:09 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>Insufficient information in abstract to assess this factor.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-02-07 11:10:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>Participant flow chart provided. Viable pregnancy determined for 1 each of expectant and surgical groups. Lost to follow up (&lt; 14 days and 8 weeks): expectant, 5 and 6, respectively (11/398 = 2.7%); surgical, 8 and 2, respectively (10/402 = 2.5%).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-01-28 17:48:04 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>Primary analysis included all women randomized. No mention of losses.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2011-11-30 18:35:56 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-28 18:40:47 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>All specified outcomes were reported in the paper. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:10:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>All specified outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-11-30 18:35:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>The analysis section identified the outcomes that were examined, and all were included in the results. Study purpose did not list the specific outcomes, however.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-02-02 15:59:20 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>Report includes data by study arm for all specified outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-26 20:26:26 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>Insufficient information in abstract. Objective addressed safety and efficacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:12:59 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>Report includes results by study arm for specified outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-01-28 18:38:28 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="YES" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>Study outcomes were specified. Report had results for all outcomes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-02-07 10:47:28 +0000" MODIFIED_BY="Denise Atherton" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-02-07 10:47:28 +0000" MODIFIED_BY="Denise Atherton" RESULT="UNKNOWN" STUDY_ID="STD-Chipchase-1997">
<DESCRIPTION>
<P>Women were assessed at 1 week, 2 weeks, and 6 months. However, authors did not report when follow-up data were obtained for most outcomes. Pregnancy was reported for the 6-month timeframe.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:10:54 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Karlsen-2001">
<DESCRIPTION>
<P>No other bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:11:10 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Nielsen-1995">
<DESCRIPTION>
<P>No other bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:11:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Shelley-2005">
<DESCRIPTION>
<P>No other bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-08 14:45:19 +0000" MODIFIED_BY="Laureen M Lopez" RESULT="UNKNOWN" STUDY_ID="STD-Thong-2002">
<DESCRIPTION>
<P>Abstract had limited information; assessment of other bias was not feasible.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:13:00 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Trinder-2006">
<DESCRIPTION>
<P>No other bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-07-01 14:13:21 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<DESCRIPTION>
<P>No other bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES MODIFIED="2011-11-28 16:14:58 +0000" MODIFIED_BY="Denise Atherton"/>
<ADDITIONAL_TABLES MODIFIED="2012-02-07 10:57:25 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2012-02-07 10:57:25 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2011-11-28 16:14:52 +0000" MODIFIED_BY="[Empty name]">Meta-analyses for expectant care versus surgical management</TITLE>
<TABLE COLS="4" ROWS="8">
<TR>
<TH>
<P>Outcome</P>
</TH>
<TH ALIGN="CENTER">
<P>Effect estimate (95% CI)</P>
</TH>
<TH ALIGN="CENTER">
<P>Participants<BR/>(trials)<SUP>a</SUP>
</P>
</TH>
<TH ALIGN="CENTER">
<P>Quality of<BR/>evidence<SUP>b</SUP>
</P>
</TH>
</TR>
<TR>
<TD>
<P>Incomplete miscarriage (&lt;= 2 weeks)</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 3.98 (95% CI 2.94 to 5.38)</P>
</TD>
<TD ALIGN="RIGHT">
<P>1263<BR/>(4)</P>
</TD>
<TD ALIGN="LEFT">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Incomplete miscarriage (6 to 8 weeks)</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 2.56 (95% CI 1.15 to 5.69)</P>
</TD>
<TD ALIGN="RIGHT">
<P>430<BR/>(3)</P>
</TD>
<TD ALIGN="LEFT">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Need for additional or unplanned surgery</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 7.35 (95% CI 5.04 to 10.72)</P>
</TD>
<TD ALIGN="RIGHT">
<P>1454<BR/>(5)</P>
</TD>
<TD ALIGN="LEFT">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Pelvic infection by 8 weeks</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 0.63 (95% CI 0.36 to 1.12)</P>
</TD>
<TD ALIGN="RIGHT">
<P>1514<BR/>(7)</P>
</TD>
<TD ALIGN="LEFT">
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Bleeding, days</P>
</TD>
<TD ALIGN="CENTER">
<P>MD 1.59 (95% CI 0.74 to 2.45)</P>
</TD>
<TD ALIGN="RIGHT">
<P>249<BR/>(2)</P>
</TD>
<TD ALIGN="LEFT">
<P>Moderate</P>
</TD>
</TR>
<TR>
<TD>
<P>Bleeding, needed transfusion</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 6.45 (95% CI 1.21 to 34.42)</P>
</TD>
<TD ALIGN="RIGHT">
<P>1205<BR/>(3)</P>
</TD>
<TD ALIGN="LEFT">
<P>High</P>
</TD>
</TR>
<TR>
<TD>
<P>Participant satisfaction</P>
</TD>
<TD ALIGN="CENTER">
<P>RR 1.11 (95% CI 0.87 to 1.44)</P>
</TD>
<TD ALIGN="RIGHT">
<P>60<BR/>(2)</P>
</TD>
<TD ALIGN="LEFT">
<P>Low</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a </SUP>Number of participants (number of trials)</P>
<P>
<SUP>b</SUP>Grades could be high, moderate, low, or very low. RCTs were considered high quality, and downgraded one level for each of the following: outcome subject to bias (assessor not blinded, self-report bias likely); losses &gt; 20% for outcome.</P>
<P>CI: confidence interval; MD: mean difference; RR: risk ratio</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
<ADDITIONAL_TABLE ID="TBL-02" MODIFIED="2011-11-28 16:14:58 +0000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2011-11-28 16:14:58 +0000" MODIFIED_BY="[Empty name]">Single-study analyses for expectant care versus surgical management</TITLE>
<TABLE COLS="7" ROWS="8">
<TR>
<TH>
<P>Study</P>
</TH>
<TH ALIGN="CENTER">
<P>Bleeding</P>
</TH>
<TH ALIGN="CENTER">
<P>Pain</P>
</TH>
<TH ALIGN="CENTER">
<P>Sick leave</P>
</TH>
<TH ALIGN="CENTER">
<P>Costs</P>
</TH>
<TH ALIGN="CENTER">
<P>Psychological</P>
</TH>
<TH ALIGN="CENTER">
<P>Subsequent<BR/>pregnancy<BR/>or live birth</P>
</TH>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>
</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Similar</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>
</P>
</TD>
<TD>
<P>Worse</P>
</TD>
<TD>
<P>Worse</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>
</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Shelley-2005" TYPE="STUDY">Shelley 2005</LINK>
</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P>Similar<BR/>(4 measures)<BR/>
</P>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Trinder-2006" TYPE="STUDY">Trinder 2006</LINK>
</P>
</TD>
<TD>
<P>Worse<BR/>(2 measures)</P>
</TD>
<TD>
<P>Worse</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P>Lower</P>
</TD>
<TD>
<P>Similar<BR/>(2 measures)</P>
</TD>
<TD>
<P>Similar</P>
</TD>
</TR>
<TR>
<TD>
<P>
<LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>
</P>
</TD>
<TD>
<P>Similar, worse<BR/>(2 measures)</P>
</TD>
<TD>
<P>Similar</P>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
<TD>
<P/>
</TD>
</TR>
<TR>
<TD>
<P>
<B>Quality of evidence<SUP>a</SUP>
</B>
</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD>
<P>Low</P>
</TD>
<TD>
<P>High</P>
</TD>
<TD>
<P>Moderate</P>
</TD>
<TD>
<P>Low</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>
<SUP>a</SUP>Grades could be high, moderate, low, or very low. RCTs were considered high quality: downgraded one level for each of the following: outcome subject to bias (assessor not blinded or self-report bias likely); losses &gt; 20% for outcome.</P>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-02-07 15:27:39 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-02-07 15:27:39 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Expectant care versus surgical treatment for miscarriage</NAME>
<DICH_OUTCOME CHI2="1.8574807460386245" CI_END="5.377469250710969" CI_START="2.9433349087044385" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="3.9784033186822945" ESTIMABLE="YES" EVENTS_1="198" EVENTS_2="46" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.7305779356964636" LOG_CI_START="0.4688396813068738" LOG_EFFECT_SIZE="0.5997088085016686" METHOD="MH" MODIFIED="2011-12-08 16:00:11 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6025072553835049" P_Q="1.0" P_Z="2.669776926212061E-19" Q="0.0" RANDOM="NO" SCALE="124.56" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="676" TOTAL_2="587" WEIGHT="100.0" Z="8.981550431868774">
<NAME>Miscarriage not complete (&lt;= 2 weeks)</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="76.64788945090157" CI_START="1.4664613680058116" EFFECT_SIZE="10.601941747572816" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="1" LOG_CI_END="1.8845002007762166" LOG_CI_START="0.16627062655087596" LOG_EFFECT_SIZE="1.0253854136635463" MODIFIED="2011-02-02 15:33:07 +0000" MODIFIED_BY="[Empty name]" ORDER="139" O_E="0.0" SE="1.0092965572735304" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" VAR="1.0186795405242008" WEIGHT="2.8139086504813466"/>
<DICH_DATA CI_END="75.65929778199892" CI_START="0.21147433916320013" EFFECT_SIZE="4.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="0" LOG_CI_END="1.878862306150246" LOG_CI_START="-0.6747423234943214" LOG_EFFECT_SIZE="0.6020599913279624" MODIFIED="2011-01-28 20:39:10 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="136" O_E="0.0" SE="1.4999999999999998" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="2.2499999999999996" WEIGHT="1.1762563129034755"/>
<DICH_DATA CI_END="15.70404355752842" CI_START="2.056737871147978" EFFECT_SIZE="5.683229813664596" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="4" LOG_CI_END="1.1960114911747315" LOG_CI_START="0.31317894489446557" LOG_EFFECT_SIZE="0.7545952180345985" MODIFIED="2011-01-28 20:27:23 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="138" O_E="0.0" SE="0.5185802077766122" STUDY_ID="STD-Thong-2002" TOTAL_1="161" TOTAL_2="122" VAR="0.2689254318976343" WEIGHT="9.636157723800062"/>
<DICH_DATA CI_END="4.908330903844917" CI_START="2.5996831499683437" EFFECT_SIZE="3.5721289373697758" ESTIMABLE="YES" EVENTS_1="145" EVENTS_2="41" LOG_CI_END="0.6909338337757401" LOG_CI_START="0.414920419276303" LOG_EFFECT_SIZE="0.5529271265260216" MODIFIED="2011-01-28 20:27:23 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="135" O_E="0.0" SE="0.16213164596540638" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="0.02628667062345188" WEIGHT="86.3736773128151"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.4256355874655271" CI_END="5.686020310401341" CI_START="1.15492711121887" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="2.562603951340051" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="7" I2="0.0" I2_Q="100.0" ID="CMP-001.02" LOG_CI_END="0.7548084066522556" LOG_CI_START="0.06255457626771778" LOG_EFFECT_SIZE="0.4086814914599866" METHOD="MH" MODIFIED="2011-12-08 16:01:51 +0000" MODIFIED_BY="Laureen M Lopez" NO="2" P_CHI2="0.8083035093041189" P_Q="0.0" P_Z="0.020657689016815785" Q="7.454431368866405E-32" RANDOM="NO" SCALE="98.38" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="239" TOTAL_2="191" WEIGHT="99.99999999999999" Z="2.314182946347129">
<NAME>Miscarriage not complete (6 to 8 weeks)</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="98.20668387837253" CI_START="0.31932653421877966" EFFECT_SIZE="5.6" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.9921410465722078" LOG_CI_START="-0.49576499255980705" LOG_EFFECT_SIZE="0.7481880270062004" MODIFIED="2011-01-28 20:20:28 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="96" O_E="0.0" SE="1.4614083227196584" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="2.1357142857142852" WEIGHT="6.730471573572792"/>
<DICH_DATA CI_END="6.386245588628608" CI_START="0.6799667574925943" EFFECT_SIZE="2.0838509316770186" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="4" LOG_CI_END="0.8052456156965967" LOG_CI_START="-0.1675123187502743" LOG_EFFECT_SIZE="0.31886664847316115" MODIFIED="2011-01-28 20:40:43 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="52726" O_E="0.0" SE="0.5714028259235265" STUDY_ID="STD-Thong-2002" TOTAL_1="161" TOTAL_2="122" VAR="0.3265011894733919" WEIGHT="55.13754521615251"/>
<DICH_DATA CI_END="9.55987235091014" CI_START="0.7731904037187575" EFFECT_SIZE="2.71875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="3" LOG_CI_END="0.9804520933571189" LOG_CI_START="-0.11171354475969388" LOG_EFFECT_SIZE="0.4343692742987125" ORDER="52727" O_E="0.0" SE="0.6415435021369164" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="0.4115780651340996" WEIGHT="38.1319832102747"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.839882621826275" CI_END="10.723833028404549" CI_START="5.0414900964361955" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="7.3528292519639615" ESTIMABLE="YES" EVENTS_1="215" EVENTS_2="27" I2="54.750530395915824" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="1.0303500433370385" LOG_CI_START="0.7025589183926909" LOG_EFFECT_SIZE="0.8664544808648647" METHOD="MH" MODIFIED="2011-11-30 17:30:07 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0652287113798774" P_Q="1.0" P_Z="3.7072447347752085E-25" Q="0.0" RANDOM="NO" SCALE="807.83" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="772" TOTAL_2="682" WEIGHT="100.0" Z="10.361595830435062">
<NAME>Needed (additional or unplanned) surgical evacuation</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="266.22112365011964" CI_START="0.9186211709685915" EFFECT_SIZE="15.638297872340425" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.4252425121481163" LOG_CI_START="-0.03686354985116149" LOG_EFFECT_SIZE="1.1941894811484774" ORDER="52728" O_E="0.0" SE="1.4462532884399422" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" VAR="2.0916485743233464" WEIGHT="1.7199386213469465"/>
<DICH_DATA CI_END="354.7358790930068" CI_START="1.3536826267064233" EFFECT_SIZE="21.91346153846154" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.5499051165916815" LOG_CI_START="0.13151685517150952" LOG_EFFECT_SIZE="1.3407109858815953" MODIFIED="2011-02-02 15:34:05 +0000" MODIFIED_BY="[Empty name]" ORDER="52729" O_E="0.0" SE="1.4205732359731722" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" VAR="2.01802831876329" WEIGHT="2.327126601914611"/>
<DICH_DATA CI_END="6.697547221095885" CI_START="0.1929010728774896" EFFECT_SIZE="1.1366459627329193" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8259157842868275" LOG_CI_START="-0.7146653568896679" LOG_EFFECT_SIZE="0.05562521369857978" ORDER="52730" O_E="0.0" SE="0.9049449883267128" STUDY_ID="STD-Thong-2002" TOTAL_1="161" TOTAL_2="122" VAR="0.8189254318976342" WEIGHT="7.9943978141608625"/>
<DICH_DATA CI_END="12.378342373326621" CI_START="5.3348798442733525" EFFECT_SIZE="8.126313385107355" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="22" LOG_CI_END="1.0926624907004823" LOG_CI_START="0.727124642400283" LOG_EFFECT_SIZE="0.9098935665503827" MODIFIED="2011-01-27 19:54:50 +0000" MODIFIED_BY="[Empty name]" ORDER="59" O_E="0.0" SE="0.2147187415330685" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="0.046104137965544675" WEIGHT="76.90101737113463"/>
<DICH_DATA CI_END="7.7978848520688455" CI_START="0.573419941232499" EFFECT_SIZE="2.1145833333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.8919768178639796" LOG_CI_START="-0.2415272081166906" LOG_EFFECT_SIZE="0.3252248048736445" ORDER="52731" O_E="0.0" SE="0.6658258757964662" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="0.44332409688013136" WEIGHT="11.057519591442944"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="4.67175928285339" CI_END="11.675800805799993" CI_START="5.335715108553741" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="7.892955515139495" ESTIMABLE="YES" EVENTS_1="212" EVENTS_2="25" I2="35.78436262735529" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="1.0672866771279135" LOG_CI_START="0.7271926331112505" LOG_EFFECT_SIZE="0.897239655119582" METHOD="MH" MODIFIED="2011-12-08 15:51:27 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.19747202740891312" P_Q="1.0" P_Z="4.568699189707439E-25" Q="0.0" RANDOM="NO" SCALE="401.0927257502627" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="611" TOTAL_2="560" WEIGHT="100.00000000000001" Z="10.341594864562571">
<NAME>Needed (additional or unplanned) surgical evacuation (sensitivity analysis)</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="266.22112365011964" CI_START="0.9186211709685915" EFFECT_SIZE="15.638297872340425" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.4252425121481163" LOG_CI_START="-0.03686354985116149" LOG_EFFECT_SIZE="1.1941894811484774" MODIFIED="2011-02-01 19:42:35 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="321" O_E="0.0" SE="1.4462532884399422" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" VAR="2.0916485743233464" WEIGHT="1.8693846684171456"/>
<DICH_DATA CI_END="354.7358790930068" CI_START="1.3536826267064233" EFFECT_SIZE="21.91346153846154" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="0" LOG_CI_END="2.5499051165916815" LOG_CI_START="0.13151685517150952" LOG_EFFECT_SIZE="1.3407109858815953" MODIFIED="2011-02-02 15:34:39 +0000" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="1.4205732359731722" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" VAR="2.01802831876329" WEIGHT="2.529331417465345"/>
<DICH_DATA CI_END="12.378342373326621" CI_START="5.3348798442733525" EFFECT_SIZE="8.126313385107355" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="22" LOG_CI_END="1.0926624907004823" LOG_CI_START="0.727124642400283" LOG_EFFECT_SIZE="0.9098935665503827" MODIFIED="2011-02-01 19:42:35 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="318" O_E="0.0" SE="0.2147187415330685" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="0.046104137965544675" WEIGHT="83.58297271486227"/>
<DICH_DATA CI_END="7.7978848520688455" CI_START="0.573419941232499" EFFECT_SIZE="2.1145833333333335" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="3" LOG_CI_END="0.8919768178639796" LOG_CI_START="-0.2415272081166906" LOG_EFFECT_SIZE="0.3252248048736445" MODIFIED="2011-02-01 19:42:35 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="322" O_E="0.0" SE="0.6658258757964662" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="0.44332409688013136" WEIGHT="12.018311199255258"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.357786517908048" CI_END="1.1206283705616356" CI_START="0.35507128775773655" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6307954966811145" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="25" I2="10.655427794467244" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.04946161315421599" LOG_CI_START="-0.4496844447711241" LOG_EFFECT_SIZE="-0.2001114158084541" METHOD="MH" MODIFIED="2011-12-08 16:02:14 +0000" MODIFIED_BY="Laureen M Lopez" NO="5" P_CHI2="0.33968055995501134" P_Q="1.0" P_Z="0.11605990254523407" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="805" TOTAL_2="709" WEIGHT="100.0" Z="1.571528660408871">
<NAME>Localized pelvic infection by 8 weeks</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="12.416103489520237" CI_START="0.057114639454864016" EFFECT_SIZE="0.8421052631578947" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.0939853238190957" LOG_CI_START="-1.2432525604129039" LOG_EFFECT_SIZE="-0.07463361829690421" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="203" O_E="0.0" SE="1.3729051027119943" STUDY_ID="STD-Chipchase-1997" TOTAL_1="19" TOTAL_2="16" VAR="1.8848684210526316" WEIGHT="3.9295014227807847"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="208" O_E="0.0" SE="0.0" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.2185590230974361" CI_START="0.07529881970385224" EFFECT_SIZE="0.3029126213592233" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.08584656986437157" LOG_CI_START="-1.1232118312378305" LOG_EFFECT_SIZE="-0.5186826306867294" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="205" O_E="0.0" SE="0.7102068897430427" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" VAR="0.5043938262384864" WEIGHT="24.050683580856926"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="206" O_E="0.0" SE="0.0" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.080439620628198" CI_START="0.005654952973959534" EFFECT_SIZE="0.10846560846560846" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.3181551160393195" LOG_CI_START="-2.247571002274299" LOG_EFFECT_SIZE="-0.9647079431174899" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="202" O_E="0.0" SE="1.5071202224465372" STUDY_ID="STD-Thong-2002" TOTAL_1="161" TOTAL_2="122" VAR="2.2714113649072996" WEIGHT="14.400915186534567"/>
<DICH_DATA CI_END="1.7864408104316936" CI_START="0.4372335073072695" EFFECT_SIZE="0.8837939698492462" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.25198863143756517" LOG_CI_START="-0.3592865633713742" LOG_EFFECT_SIZE="-0.053648965966904556" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="204" O_E="0.0" SE="0.35906607529178575" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="0.12892844642544635" WEIGHT="57.61889980982772"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-02-02 16:07:42 +0000" MODIFIED_BY="[Empty name]" ORDER="207" O_E="0.0" SE="0.0" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.424693045035815" CI_END="2.4476651616917593" CI_START="0.7422689154607128" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.594967038576236" ESTIMABLE="YES" I2="29.809441866485617" I2_Q="0.0" ID="CMP-001.06" MODIFIED="2011-11-30 17:39:46 +0000" MODIFIED_BY="Laureen M Lopez" NO="6" P_CHI2="0.2326327413698781" P_Q="1.0" P_Z="2.46276113960948E-4" Q="0.0" RANDOM="NO" SCALE="5.010655363558759" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="149" TOTAL_2="100" UNITS="" WEIGHT="100.0" Z="3.66610159843686">
<NAME>Mean (standard deviation) days of bleeding</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.973065099852498" CI_START="0.8269349001475026" EFFECT_SIZE="2.4000000000000004" ESTIMABLE="YES" MEAN_1="7.2" MEAN_2="4.8" ORDER="52745" SD_1="4.72" SD_2="2.77" SE="0.8025989825632688" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" WEIGHT="29.383073559319023"/>
<CONT_DATA CI_END="2.274707572554771" CI_START="0.2452924274452266" EFFECT_SIZE="1.259999999999999" ESTIMABLE="YES" MEAN_1="8.79" MEAN_2="7.53" ORDER="52746" SD_1="3.01" SD_2="3.06" SE="0.5177174583607944" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" WEIGHT="70.61692644068097"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.07" MODIFIED="2011-11-30 17:39:46 +0000" MODIFIED_BY="Laureen M Lopez" NO="7" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO">
<NAME>Days of bleeding reported as medians</NAME>
<TR>
<TH>
<P>Study group</P>
</TH>
<TH>
<P>Median</P>
</TH>
<TH>
<P>Range</P>
</TH>
<TH>
<P>Percentiles: 25th, 75th</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2011-01-27 19:46:44 +0000" MODIFIED_BY="[Empty name]" ORDER="26" STUDY_ID="STD-Chipchase-1997">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>0 to 7</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>0 to 7</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2011-01-27 19:47:52 +0000" MODIFIED_BY="[Empty name]" ORDER="27" STUDY_ID="STD-Trinder-2006">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD/>
<TD>
<P>7, 15</P>
</TD>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD/>
<TD>
<P>4, 14</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2011-01-27 19:47:36 +0000" MODIFIED_BY="[Empty name]" ORDER="28" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>17</P>
</TD>
<TD/>
<TD>
<P>10, 26</P>
</TD>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>13</P>
</TD>
<TD/>
<TD>
<P>9, 17</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.5235899674057456" CI_START="0.5365621475508908" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.5469853647644769" LOG_CI_START="-0.270379968431914" LOG_EFFECT_SIZE="0.13830269816628146" METHOD="MH" MODIFIED="2011-11-30 17:42:20 +0000" MODIFIED_BY="Laureen M Lopez" NO="8" P_CHI2="1.0" P_Q="1.0" P_Z="0.5071555276158461" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="11" WEIGHT="100.0" Z="0.6632733157658769">
<NAME>Bleeding &gt;= 9 days</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.5235899674057447" CI_START="0.5365621475508908" EFFECT_SIZE="1.375" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="4" LOG_CI_END="0.5469853647644768" LOG_CI_START="-0.270379968431914" LOG_EFFECT_SIZE="0.13830269816628146" MODIFIED="2011-01-27 19:06:47 +0000" MODIFIED_BY="[Empty name]" ORDER="50" O_E="0.0" SE="0.48012444274321264" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="0.23051948051948049" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0335750332990457" CI_END="34.42032114209201" CI_START="1.209434975877285" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="6.452064806724622" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="1.5368149179842152" LOG_CI_START="0.08258252389524434" LOG_EFFECT_SIZE="0.8096987209397297" METHOD="MH" MODIFIED="2011-12-08 16:02:43 +0000" MODIFIED_BY="Laureen M Lopez" NO="9" P_CHI2="0.5964335861713004" P_Q="1.0" P_Z="0.029067660037987123" Q="0.0" RANDOM="NO" SCALE="347.26" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="623" TOTAL_2="582" WEIGHT="100.0" Z="2.182567707638241">
<NAME>Bleeding with need for transfusion</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="55.4351112562092" CI_START="0.09359179565743436" EFFECT_SIZE="2.2777777777777777" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7437849234784253" LOG_CI_START="-1.0287622202455664" LOG_EFFECT_SIZE="0.3575113516164294" ORDER="52747" O_E="0.0" SE="1.6286079165531773" STUDY_ID="STD-Thong-2002" TOTAL_1="161" TOTAL_2="122" VAR="2.6523637458596805" WEIGHT="35.7470350658554"/>
<DICH_DATA CI_END="264.380026269027" CI_START="0.8681967936761081" EFFECT_SIZE="15.150375939849624" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.422228641400547" LOG_CI_START="-0.06138182238046185" LOG_EFFECT_SIZE="1.1804234095100425" MODIFIED="2011-01-27 19:50:25 +0000" MODIFIED_BY="[Empty name]" ORDER="58" O_E="0.0" SE="1.4588850804950364" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="2.128345678091009" WEIGHT="31.287322530970002"/>
<DICH_DATA CI_END="65.55615627880522" CI_START="0.11311138953080221" EFFECT_SIZE="2.723076923076923" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.81661348187464" LOG_CI_START="-0.946493662436738" LOG_EFFECT_SIZE="0.4350599097189511" ORDER="52748" O_E="0.0" SE="1.6230628141694574" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="2.6343328987396784" WEIGHT="32.96564240317459"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="19.46697022043318" CI_START="0.16875539505124382" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.8125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="1.2892983645176297" LOG_CI_START="-0.772742334031567" LOG_EFFECT_SIZE="0.2582780152430313" METHOD="MH" MODIFIED="2012-02-07 15:27:39 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="1.0" P_Q="1.0" P_Z="0.6234370024880932" Q="0.0" RANDOM="NO" SCALE="478.14" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="58" WEIGHT="100.0" Z="0.4909850792285428">
<NAME>Hemorrhage &gt; 500 mL</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="19.46697022043318" CI_START="0.16875539505124376" EFFECT_SIZE="1.8125" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2892983645176297" LOG_CI_START="-0.7727423340315671" LOG_EFFECT_SIZE="0.2582780152430313" ORDER="52749" O_E="0.0" SE="1.2112529135938768" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="1.4671336206896552" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.7179165668377305" CI_START="-0.25791656683773057" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.22999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.11" MODIFIED="2011-11-30 17:47:37 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="1.0" P_Q="1.0" P_Z="0.35553241731210605" Q="0.0" RANDOM="NO" SCALE="3.11" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="0.9239114780747649">
<NAME>Mean (standard deviation) days of pain</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.7179165668377305" CI_START="-0.25791656683773057" EFFECT_SIZE="0.22999999999999998" ESTIMABLE="YES" MEAN_1="1.92" MEAN_2="1.69" ORDER="52743" SD_1="1.47" SD_2="1.46" SE="0.24894159825708745" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="4" ID="CMP-001.12" MODIFIED="2011-11-30 17:39:42 +0000" MODIFIED_BY="Laureen M Lopez" NO="12" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO">
<NAME>Days of pain reported as medians</NAME>
<TR>
<TH>
<P>Study group</P>
</TH>
<TH>
<P>Median days</P>
</TH>
<TH>
<P>Range</P>
</TH>
<TH>
<P>Percentiles:25th and 75th</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2011-02-01 17:10:36 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="35" STUDY_ID="STD-Chipchase-1997">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0 to 5</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>0</P>
</TD>
<TD>
<P>0 to 2</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2011-02-01 17:10:42 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="36" STUDY_ID="STD-Shelley-2005">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>0.0 to 11.0</P>
</TD>
<TD/>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>0.2 to 12.0</P>
</TD>
<TD/>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2011-02-01 17:10:12 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="37" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>
<BR/>
</P>
</TD>
<TD>
<P>7, 24</P>
</TD>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>11</P>
</TD>
<TD/>
<TD>
<P>6, 26</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.0957029870650974" CI_START="0.30429701293490263" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.7" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.13" MODIFIED="2011-11-30 17:47:43 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="5.259431007702682E-4" Q="0.0" RANDOM="NO" SCALE="2.6" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="48" UNITS="" WEIGHT="100.0" Z="3.4671833016826166">
<NAME>Pain (scale 0 to 3)</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.0957029870650974" CI_START="0.30429701293490263" EFFECT_SIZE="0.7" ESTIMABLE="YES" MEAN_1="1.4" MEAN_2="0.7" ORDER="52744" SD_1="1.13" SD_2="0.79" SE="0.2018929889458949" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.194333317424764" CI_START="1.9848859886096484" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.518012598202279" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.5043802312656905" LOG_CI_START="0.2977355660413365" LOG_EFFECT_SIZE="0.40105789865351354" METHOD="MH" MODIFIED="2011-11-30 17:48:50 +0000" MODIFIED_BY="Laureen M Lopez" NO="14" P_CHI2="1.0" P_Q="1.0" P_Z="2.7872996860237493E-14" Q="0.0" RANDOM="NO" SCALE="3.4" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="398" TOTAL_2="402" WEIGHT="100.0" Z="7.607832858620158">
<NAME>Extra analgesic taken</NAME>
<GROUP_LABEL_1>Favours expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.194333317424764" CI_START="1.9848859886096484" EFFECT_SIZE="2.518012598202279" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="71" LOG_CI_END="0.5043802312656905" LOG_CI_START="0.2977355660413365" LOG_EFFECT_SIZE="0.40105789865351354" MODIFIED="2011-01-31 18:46:21 +0000" MODIFIED_BY="[Empty name]" ORDER="56" O_E="0.0" SE="0.12138409926037567" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" VAR="0.014734099553252736" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="9.561636417434216E-31" CI_END="-385.16368502622936" CI_START="-613.0363149737703" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-499.09999999999985" ESTIMABLE="YES" I2="100.0" I2_Q="0.0" ID="CMP-001.15" MODIFIED="2011-11-30 17:39:41 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.0" P_Q="1.0" P_Z="9.031942518146667E-18" Q="0.0" RANDOM="NO" SCALE="646.3" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="398" TOTAL_2="402" UNITS="" WEIGHT="100.0" Z="8.585656161594647">
<NAME>Costs by 8 weeks for hospital care and broader impacts (UK pounds sterling, 2001-02 prices)</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="-385.1636850262295" CI_START="-613.0363149737703" EFFECT_SIZE="-499.0999999999999" ESTIMABLE="YES" MEAN_1="1086.2" MEAN_2="1585.3" MODIFIED="2011-01-27 19:29:51 +0000" MODIFIED_BY="[Empty name]" ORDER="54" SD_1="997.7" SD_2="594.2" SE="58.13184113202364" STUDY_ID="STD-Trinder-2006" TOTAL_1="398" TOTAL_2="402" WEIGHT="100.0"/>
</CONT_OUTCOME>
<OTHER_OUTCOME COLS="3" ID="CMP-001.16" MODIFIED="2011-11-30 17:39:41 +0000" MODIFIED_BY="Laureen M Lopez" NO="16" ROWS_PER_STUDY="2" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO">
<NAME>Days of sick leave reported as medians</NAME>
<TR>
<TH>
<P>Study group</P>
</TH>
<TH>
<P>Median days</P>
</TH>
<TH>
<P>Range</P>
</TH>
</TR>
<OTHER_DATA MODIFIED="2011-01-27 20:14:36 +0000" MODIFIED_BY="[Empty name]" ORDER="41" STUDY_ID="STD-Chipchase-1997">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>4</P>
</TD>
<TD>
<P>0 to 28</P>
</TD>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>6.5</P>
</TD>
<TD>
<P>0 to 7</P>
</TD>
</TR>
</OTHER_DATA>
<OTHER_DATA MODIFIED="2011-01-27 20:14:36 +0000" MODIFIED_BY="[Empty name]" ORDER="42" STUDY_ID="STD-Trinder-2006">
<TR>
<TD>
<P>Expectant care</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
<TR>
<TD>
<P>Surgical treatment</P>
</TD>
<TD>
<P>9</P>
</TD>
<TD>
<P>---</P>
</TD>
</TR>
</OTHER_DATA>
</OTHER_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.1601616934511942" CI_START="-1.5401616934511941" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.18999999999999995" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.17" MODIFIED="2011-11-30 17:39:41 +0000" MODIFIED_BY="Laureen M Lopez" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.7826911241019624" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="103" TOTAL_2="52" UNITS="" WEIGHT="100.0" Z="0.2758137479894896">
<NAME>Days of sick leave after management of miscarriage</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.160161693451194" CI_START="-1.540161693451194" EFFECT_SIZE="-0.18999999999999995" ESTIMABLE="YES" MEAN_1="2.65" MEAN_2="2.84" ORDER="52756" SD_1="2.9" SD_2="4.52" SE="0.6888706650229786" STUDY_ID="STD-Nielsen-1995" TOTAL_1="103" TOTAL_2="52" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="11.920812571947385" CI_START="0.8285971246333055" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.142857142857143" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-001.18" LOG_CI_END="1.0763058597234472" LOG_CI_START="-0.08165657810754837" LOG_EFFECT_SIZE="0.4973246408079494" METHOD="MH" MODIFIED="2011-11-30 17:39:40 +0000" MODIFIED_BY="Laureen M Lopez" NO="18" P_CHI2="1.0" P_Q="1.0" P_Z="0.09227048804413927" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="11" WEIGHT="100.0" Z="1.6835405929637983">
<NAME>Days to return to usual activities &gt;= 7</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.920812571947385" CI_START="0.8285971246333055" EFFECT_SIZE="3.142857142857143" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="2" LOG_CI_END="1.0763058597234472" LOG_CI_START="-0.08165657810754837" LOG_EFFECT_SIZE="0.4973246408079494" MODIFIED="2011-01-27 19:03:54 +0000" MODIFIED_BY="[Empty name]" ORDER="49" O_E="0.0" SE="0.6801928679884387" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="0.46266233766233766" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.08597337019389262" CI_END="1.4355448846416579" CI_START="0.865179907857103" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1144525970264527" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="20" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="0.15701677596693686" LOG_CI_START="-0.06289357477167733" LOG_EFFECT_SIZE="0.04706160059762976" METHOD="MH" MODIFIED="2011-12-08 14:51:02 +0000" MODIFIED_BY="Laureen M Lopez" NO="19" P_CHI2="0.7693600038393091" P_Q="1.0" P_Z="0.40153745285465203" Q="0.0" RANDOM="NO" SCALE="2.62" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="33" TOTAL_2="27" WEIGHT="100.0" Z="0.83887858771867">
<NAME>Participant satisfaction with management</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4094989670311415" CI_START="0.927056723008791" EFFECT_SIZE="1.143103448275862" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="14" LOG_CI_END="0.14906476192962212" LOG_CI_START="-0.032893692245950554" LOG_EFFECT_SIZE="0.05808553484183581" ORDER="52753" O_E="0.0" SE="0.10688329669160604" STUDY_ID="STD-Chipchase-1997" TOTAL_1="19" TOTAL_2="16" VAR="0.011424039111665882" WEIGHT="69.9942073759413"/>
<DICH_DATA CI_END="2.119900104700658" CI_START="0.5177157482565504" EFFECT_SIZE="1.0476190476190477" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="6" LOG_CI_END="0.32631539630637396" LOG_CI_START="-0.28590862412979995" LOG_EFFECT_SIZE="0.02020338608828699" MODIFIED="2011-01-28 19:57:49 +0000" MODIFIED_BY="Laureen M Lopez" ORDER="46" O_E="0.0" SE="0.35962342016198595" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="11" VAR="0.1293290043290043" WEIGHT="30.0057926240587"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.088846487029894" CI_START="-6.088846487029894" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.20" MODIFIED="2011-11-30 17:39:40 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="26.580973417811524" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="58" TOTAL_2="28" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>State anxiety inventory</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="6.088846487029894" CI_START="-6.088846487029894" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="57.5" MEAN_2="57.5" ORDER="52754" SD_1="12.4" SD_2="14.0" SE="3.106611414831057" STUDY_ID="STD-Nielsen-1995" TOTAL_1="58" TOTAL_2="28" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.7291517605282847" CI_START="-12.729151760528286" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.21" MODIFIED="2011-11-30 17:39:40 +0000" MODIFIED_BY="Laureen M Lopez" NO="21" P_CHI2="1.0" P_Q="1.0" P_Z="0.135920219736635" Q="0.0" RANDOM="NO" SCALE="44.92458037435413" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="43" TOTAL_2="15" UNITS="" WEIGHT="100.0" Z="1.4911572300679634">
<NAME>State anxiety inventory within expectant care group</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.7291517605282856" CI_START="-12.729151760528286" EFFECT_SIZE="-5.5" ESTIMABLE="YES" MEAN_1="56.1" MEAN_2="61.6" ORDER="52755" SD_1="12.3" SD_2="12.3" SE="3.6884105103720843" STUDY_ID="STD-Nielsen-1995" TOTAL_1="43" TOTAL_2="15" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="26.068611252789097" CI_START="0.4892896639997136" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="3.5714285714285716" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" I2="0.0" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="1.4161178957131986" LOG_CI_START="-0.310433958397637" LOG_EFFECT_SIZE="0.5528419686577808" METHOD="MH" MODIFIED="2011-11-30 17:39:39 +0000" MODIFIED_BY="Laureen M Lopez" NO="22" P_CHI2="1.0" P_Q="1.0" P_Z="0.20942031436240638" Q="0.0" RANDOM="NO" SCALE="288.73" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="10" WEIGHT="100.0" Z="1.255161083209394">
<NAME>HADS Anxiety &gt;=11 at 8 weeks</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="26.068611252789097" CI_START="0.4892896639997136" EFFECT_SIZE="3.5714285714285716" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.4161178957131986" LOG_CI_START="-0.310433958397637" LOG_EFFECT_SIZE="0.5528419686577808" MODIFIED="2011-01-27 19:01:41 +0000" MODIFIED_BY="[Empty name]" ORDER="47" O_E="0.0" SE="1.01418510567422" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="10" VAR="1.0285714285714285" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="72.21438517391324" CI_START="0.5918291842378625" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="PETO_OR" EFFECT_SIZE="6.537475098821858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="1.8586237180594765" LOG_CI_START="-0.22780362274930646" LOG_EFFECT_SIZE="0.815410047655085" METHOD="PETO" MODIFIED="2011-11-30 17:39:39 +0000" MODIFIED_BY="Laureen M Lopez" NO="23" P_CHI2="1.0" P_Q="1.0" P_Z="0.12552929878003663" Q="0.0" RANDOM="NO" SCALE="288.73" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="10" WEIGHT="100.00000000000001" Z="1.5319721849662298">
<NAME>HADS Depression &gt;=11 at 8 weeks</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="72.2143851739133" CI_START="0.5918291842378622" EFFECT_SIZE="6.537475098821858" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="1.858623718059477" LOG_CI_START="-0.2278036227493066" LOG_EFFECT_SIZE="0.815410047655085" MODIFIED="2011-01-27 19:01:05 +0000" MODIFIED_BY="[Empty name]" ORDER="48" O_E="1.25" SE="1.225577747972984" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="10" VAR="0.6657608695652174" WEIGHT="100.00000000000001"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="8.684108193683201" CI_START="-13.884108193683204" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.6000000000000014" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.24" MODIFIED="2011-11-30 17:39:39 +0000" MODIFIED_BY="Laureen M Lopez" NO="24" P_CHI2="1.0" P_Q="1.0" P_Z="0.6515569734837462" Q="0.0" RANDOM="NO" SCALE="22.324359326958746" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="0.4516002746815926">
<NAME>SF-36 Mental health scale at 8 weeks</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<CONT_DATA CI_END="8.684108193683201" CI_START="-13.884108193683204" EFFECT_SIZE="-2.6000000000000014" ESTIMABLE="YES" MEAN_1="42.5" MEAN_2="45.1" MODIFIED="2011-01-27 19:09:15 +0000" MODIFIED_BY="[Empty name]" ORDER="45" SD_1="17.6" SD_2="11.5" SE="5.757303849810919" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="10.997170798914334" CI_START="-4.197170798914337" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="3.3999999999999986" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.25" MODIFIED="2011-11-30 17:39:38 +0000" MODIFIED_BY="Laureen M Lopez" NO="25" P_CHI2="1.0" P_Q="1.0" P_Z="0.38040380796919404" Q="0.0" RANDOM="NO" SCALE="22.324359326958746" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="14" TOTAL_2="12" UNITS="" WEIGHT="100.0" Z="0.877152524777839">
<NAME>SF-36 Physical health scale at 8 weeks</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<CONT_DATA CI_END="10.997170798914334" CI_START="-4.197170798914337" EFFECT_SIZE="3.3999999999999986" ESTIMABLE="YES" MEAN_1="56.9" MEAN_2="53.5" MODIFIED="2011-01-27 19:09:10 +0000" MODIFIED_BY="[Empty name]" ORDER="44" SD_1="8.0" SD_2="11.2" SE="3.876178776161118" STUDY_ID="STD-Shelley-2005" TOTAL_1="14" TOTAL_2="12" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.980948762054166" CI_START="0.638898402746973" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" I2="0.0" I2_Q="100.0" ID="CMP-001.26" LOG_CI_END="0.29687324250224223" LOG_CI_START="-0.19456819760747965" LOG_EFFECT_SIZE="0.05115252244738129" METHOD="MH" MODIFIED="2011-11-30 17:39:38 +0000" MODIFIED_BY="Laureen M Lopez" NO="26" P_CHI2="1.0" P_Q="0.0" P_Z="0.6832645693497879" Q="2.311115933264683E-33" RANDOM="NO" SCALE="2.5081294769081444" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="12" TOTAL_2="9" WEIGHT="100.0" Z="0.4080124040531057">
<NAME>Subsequent conception</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9809487620541661" CI_START="0.6388984027469728" EFFECT_SIZE="1.125" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.2968732425022423" LOG_CI_START="-0.19456819760747973" LOG_EFFECT_SIZE="0.05115252244738129" ORDER="52757" O_E="0.0" SE="0.2886751345948129" STUDY_ID="STD-Chipchase-1997" TOTAL_1="12" TOTAL_2="9" VAR="0.08333333333333337" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.0588983687608833" CI_START="0.8833432279505261" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9671456473214286" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="192" I2="0.0" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.02485427927234929" LOG_CI_START="-0.05387051608068829" LOG_EFFECT_SIZE="-0.014508118404169504" METHOD="MH" MODIFIED="2011-11-30 17:39:38 +0000" MODIFIED_BY="Laureen M Lopez" NO="27" P_CHI2="1.0" P_Q="1.0" P_Z="0.4700486942096236" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="224" TOTAL_2="235" WEIGHT="100.0" Z="0.7223998342097386">
<NAME>Live births by 5 years</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours surgical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours expectant</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.0588983687608833" CI_START="0.8833432279505261" EFFECT_SIZE="0.9671456473214286" ESTIMABLE="YES" EVENTS_1="177" EVENTS_2="192" LOG_CI_END="0.02485427927234929" LOG_CI_START="-0.05387051608068829" LOG_EFFECT_SIZE="-0.014508118404169504" MODIFIED="2011-01-27 19:22:47 +0000" MODIFIED_BY="[Empty name]" ORDER="52" O_E="0.0" SE="0.046243334484396145" STUDY_ID="STD-Trinder-2006" TOTAL_1="224" TOTAL_2="235" VAR="0.0021384459842357416" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="65.55615627880522" CI_START="0.11311138953080221" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.723076923076923" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.28" LOG_CI_END="1.81661348187464" LOG_CI_START="-0.946493662436738" LOG_EFFECT_SIZE="0.4350599097189511" METHOD="MH" MODIFIED="2011-11-30 17:49:55 +0000" MODIFIED_BY="Laureen M Lopez" NO="28" P_CHI2="1.0" P_Q="1.0" P_Z="0.5370995303752315" Q="0.0" RANDOM="NO" SCALE="583.5" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="64" TOTAL_2="58" WEIGHT="100.0" Z="0.6172049867280134">
<NAME>Cervical tear</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="65.55615627880522" CI_START="0.11311138953080221" EFFECT_SIZE="2.723076923076923" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.81661348187464" LOG_CI_START="-0.946493662436738" LOG_EFFECT_SIZE="0.4350599097189511" ORDER="52751" O_E="0.0" SE="1.6230628141694574" STUDY_ID="STD-Wieringa_x002d_de-Waard-2002a" TOTAL_1="64" TOTAL_2="58" VAR="2.6343328987396784" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.29" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-11-30 17:50:14 +0000" MODIFIED_BY="Laureen M Lopez" NO="29" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="48" TOTAL_2="46" WEIGHT="0.0" Z="0.0">
<NAME>Endometritis</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52742" O_E="0.0" SE="0.0" STUDY_ID="STD-Karlsen-2001" TOTAL_1="48" TOTAL_2="46" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.30" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2011-11-30 17:50:25 +0000" MODIFIED_BY="Laureen M Lopez" NO="30" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="46" TOTAL_2="48" WEIGHT="0.0" Z="0.0">
<NAME>Perioperative complications</NAME>
<GROUP_LABEL_1>Expectant</GROUP_LABEL_1>
<GROUP_LABEL_2>Surgical</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours expectant</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours surgical</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="52752" O_E="0.0" SE="0.0" STUDY_ID="STD-Karlsen-2001" TOTAL_1="46" TOTAL_2="48" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2011-06-30 11:25:33 +0100" MODIFIED_BY="[Empty name]"/>
<FEEDBACK/>
<APPENDICES MODIFIED="2012-02-10 13:23:03 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2012-02-10 13:23:03 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-01-11 17:02:28 +0000" MODIFIED_BY="Laureen M Lopez">Search strategies for 2012 update</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-10 13:23:03 +0000" MODIFIED_BY="[Empty name]">
<P>Authors wrote and conducted the following searches:</P>
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL, The Cochrane Central Library of Controlled Trials (<I>The Cochrane Library</I> 2011, Issue 4 of 4)</HEADING>
<P>miscarriage OR "abortion missed" OR "abortion inevitable" OR "abortion spontaneous" OR "abortion incomplete" OR "vacuum curettage" OR "dilation and curettage" in Title, Abstract or Keywords<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE via PubMed (1 January 2005 to 11 January 2012)</HEADING>
<P>abortion, spontaneous/therapy OR ((abortion, spontaneous OR miscarriage OR abortion, inevitable OR dilation and curettage) AND (maternal health services OR patient care OR expectant therapeutics OR expectant management OR expectant care OR expectant treatment OR conservative management OR conservative treatment))<BR/>Limits Activated: Clinical Trial, Randomized Controlled Trial</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">POPLINE (inception to 11 January 2012)</HEADING>
<P>(spontaneous abortion/miscarriage) &amp; (treatment/management/care)</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">LILACS (1 January 2005 to 11 January 2012)</HEADING>
<P>ABORTION, SPONTANEOUS or Aborto Espontáneo or ABORTION, MISSED or Aborto Retenido or Aborto Retido or ABORTION, INCOMPLETE or Aborto Incompleto or abortion, inevitable or Dilatation and Curettage or Dilatación y Legrado Uterino or Dilatação e Curetagem or VACUUM CURETTAGE or Legrado por Aspiración or Curetagem a Vácuo [Words] and "CARE" or Atención or Assistência or "MANAGEMENT" or Gerencia or Gerência or "TREATMENT" or Tratamiento or Tratamento [Words]</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2011-02-01 14:55:50 +0000" MODIFIED_BY="Laureen M Lopez" NO="2">
<TITLE MODIFIED="2011-01-25 18:08:10 +0000" MODIFIED_BY="Laureen M Lopez">Search strategies for the initial review</TITLE>
<APPENDIX_BODY MODIFIED="2011-02-01 14:55:50 +0000" MODIFIED_BY="Laureen M Lopez">
<SUBSECTION>
<HEADING LEVEL="3">CENTRAL (2004, Issue 3)</HEADING>
<OL>
<LI>miscarriage;</LI>
<LI>abortion missed;</LI>
<LI>abortion inevitable;</LI>
<LI>abortion spontaneous;</LI>
<LI>abortion incomplete;</LI>
<LI>vacuum curettage;</LI>
<LI>dilation and curettage.</LI>
</OL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">MEDLINE via PubMed (inception to March 2005)</HEADING>
<P>abortion, spontaneous/therapy OR (miscarriage OR abortion, inevitable OR dilation and curettage OR vacuum curettage)) AND (patient care OR expectant management OR expectant care OR expectant treatment OR conservative management OR conservative treatment)<BR/>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">POPLINE (inception to March 2005)</HEADING>
<P>((abortion spontaneous &amp; (treatment /management/care)) &amp; clinical research</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">LILACS (1982 to March 2005)</HEADING>
<P>((((( "ABORTION, SPONTANEOUS" ) or "ABORTION, MISSED/" ) or "ABORTION, INCOMPLETE" or "abortion, inevitable" ) or "DILATION" ) or "CURETTAGE" ) or "VACUUM CURETTAGE" [Words] and ( ( "CARE" ) or "MANAGEMENT" ) or "TREATMENT" [Words] ))</P>
</SUBSECTION>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-02-07 11:08:45 +0000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2011-12-01 15:57:49 +0000" MODIFIED_BY="Jill V Hampson">Methods, Data collection and analysis, initial review (2006)</TITLE>
<APPENDIX_BODY MODIFIED="2012-02-07 11:08:45 +0000" MODIFIED_BY="[Empty name]">
<P>The following methods were used to assess included trials in the initial review, published in 2006 (<LINK REF="STD-Chipchase-1997" TYPE="STUDY">Chipchase 1997</LINK>; <LINK REF="STD-Karlsen-2001" TYPE="STUDY">Karlsen 2001</LINK>; <LINK REF="STD-Nielsen-1995" TYPE="STUDY">Nielsen 1995</LINK>; <LINK REF="STD-Thong-2002" TYPE="STUDY">Thong 2002</LINK>; <LINK REF="STD-Wieringa_x002d_de-Waard-2002a" TYPE="STUDY">Wieringa-de Waard 2002a</LINK>).</P>
<P>We evaluated the trials using standard criteria without consideration of results (<LINK REF="REF-Alderson-2004" TYPE="REFERENCE">Alderson 2004</LINK>; <LINK REF="REF-Moher-2001" TYPE="REFERENCE">Moher 2001</LINK>). Two authors independently reviewed all identified trials for inclusion and study quality. Trials without random allocation were excluded without further evaluation. We appraised the trials by examining the following factors: study design, blinding, randomization method, group allocation concealment, exclusions after randomization, loss to follow up and early discontinuation. We resolved discrepancies or disagreements by discussion.</P>
<P>For included studies, each author extracted data independently. Data were compared and reconciled data were entered into Review Manager (<LINK REF="REF-RevMan-2003" TYPE="REFERENCE">RevMan 2003</LINK>). We calculated the relative risk (RR) for dichotomous outcomes and the weighted mean difference (WMD) for continuous data. For all data, we also computed 95% confidence intervals (CI). We entered additional data such as medians into 'Other data' tables. The data in the present review were generally based on the analytic method used in the trial report (for example, intention to treat or per protocol). Any reasons for exception are given with the results. In the Results, we emphasized the important differences. That is, we included the estimates and CI for the results that were significant (P &lt; 0.05). The less important findings are mentioned, and the specific numbers can be found in the tables and figures.</P>
<P>In a subgroup analysis, we intended to examine outcomes for incomplete or inevitable miscarriage (where bleeding has already begun) versus non-viable pregnancy (without bleeding). For the participants having ultrasound examination, we also intended to examine outcomes for embryonic death (less than eight weeks' gestation) versus fetal death (at least eight weeks' gestation). However, we found no studies that reported data separately for non-viable pregnancies documented by ultrasound examination.</P>
<P>For the included studies, we collected information on method of randomization, method of allocation concealment, study setting, details of participants, potential co-interventions (such as bedrest, ultrasound, or antibiotics), power, and completeness of follow-up. Lastly, we collected information on masking of outcome assessment or analysis. If information was lacking in the study reports, we contacted the authors.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>